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Abstract
Healthcare delivery organizations have an opportunity to use insights from the emerging
field of precision medicine to improve the quality of patient care; however, information
technology resources to fully enable precision medicine are lacking. The specific problem
was that people have limited information to use when making decisions regarding
information technology resources for precision medicine in healthcare delivery
organizations given the emerging state of precision medicine. The purpose of this Delphi
study was to determine how a panel of precision medicine information technology
experts view information technology resource importance and feasibility for precision
medicine in healthcare delivery organizations. The research question asked how does a
panel of precision medicine information technology experts view information technology
resource importance and feasibility for precision medicine in healthcare delivery
organizations. The resource-based view of the firm served as the conceptual framework.
Data were collected in three consecutive rounds of questionnaires. Thematic analysis was
performed to develop a list of information technology resources that were rated by
participants in terms of importance and feasibility, which were analyzed to assess if there
was consensus among the participants. Of the 159 information technology resources that
were rated, 77 information technology resources were considered important and feasible.
The study results could lead to positive social change at individual, organizational, and
societal levels. At a societal level, the study results could give rise to positive social
change by creating a shared vision of what is needed to fulfill information technology
resource requirements for precision medicine in healthcare delivery organizations and
enable progress toward improved healthcare quality.
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Chapter 1: Introduction to the Study
In this study, I focused on information technology resources that could enable
healthcare delivery organizations to improve the quality of patient care using precision
medicine. Fulfilling information technology resource requirements for precision medicine
in healthcare delivery organizations requires careful and deliberate planning. To make
sound decisions about information technology resources for precision medicine in
healthcare delivery organizations people should have information about resource
importance and feasibility. The results of this study may provide information to aid
people in making well-informed information technology resource decisions for precision
medicine in healthcare delivery organizations.
The need for this study stems from the fact that people have limited information
to use when making information technology resource decisions for precision medicine in
healthcare delivery organizations. The requirements for information technology resources
for precision medicine in healthcare delivery organizations are uncertain given that
precision medicine is an evolving field. Precision medicine is a field of diverse
applications with an abundance of new discoveries. People need additional information to
make sensible decisions about information technology resources for precision medicine
in healthcare delivery organizations.
This study could give rise to positive social change beyond potentially improving
information technology resource decisions for precision medicine in healthcare delivery
organizations. This study included determining a consensus of information technology
resource importance and feasibility for precision medicine in healthcare delivery
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organizations. A consensus of information technology resource importance and feasibility
could lead to the creation of a shared vision to meet the resource requirements for
precision medicine in healthcare delivery organizations. Meeting the information
technology resource requirements for precision medicine could enable healthcare
delivery organizations enhance the quality of patient care. This study may lead to positive
social change.
This chapter begins with the background of the study followed by the problem
statement, purpose of the study, research questions, conceptual framework, and nature of
the study. Chapter 1 also includes the definitions, assumptions, scope, delimitations, and
limitations of the study. This chapter concludes with the significance of the study and a
summary.
Background of the Study
Healthcare delivery organizations have a tremendous opportunity to use insights
from the emerging field of precision medicine to improve the quality of patient care
(Starkweather et al., 2018; Weinshilboum & Wang, 2017). Precision medicine is
applicable to practically every medical specialty (Weinshilboum & Wang, 2017). The
field of oncology provides an example in which there are promising precision medicine
advances for the prevention, diagnosis, prognosis, and treatment of cancer (Warner, Jain,
et al., 2016). The potential improvement of patient care in healthcare delivery
organizations using precision medicine is wide ranging.
Achieving the potential benefits of precision medicine entails utilizing diverse and
complex types of healthcare data with the aid of information technology (Gligorijević et
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al., 2016; Gómez-López et al., 2019). Precision medicine is transdisciplinary and
involves integrating data from multiple areas such as the clinical, molecular,
environmental, social, and behavioral domains (Beckmann & Lew, 2016; Prosperi et al.,
2018). The use of varied types of data is consistent with the precision medicine concept
that healthcare delivery improves as more health factors are measured (Vegter, 2018). As
for the need of information technology, Levy et al. (2019) explained that an important
driver of sustained precision medicine is information technology infrastructure including
electronic health record systems and clinical decision support. Information technology
aids in the use of increasing amounts of complex health data for precision medicine.
Healthcare delivery organizations are ill equipped to tackle numerous challenges
associated with using information technology for precision medicine. The information
technology challenges related to precision medicine are varied and include hardware,
software, interoperability, integration, implementation, standardization, and human
resource issues (Hulsen et al., 2019; Klein et al., 2017). Storing, processing, and
interpreting large amounts of diverse precision medicine data requires considerable
computational infrastructures that are typically not found in healthcare delivery
organizations (Gómez-López et al., 2019; Pritchard et al., 2017). Information specialists
need skills that span multiple disciplines and reports indicate that there is a shortage of
workers with the skills necessary to implement precision medicine (Gómez-López et al.,
2019; Hulsen et al., 2019). Healthcare delivery organizations have many information
technology obstacles to overcome regarding precision medicine.
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In this study, I addressed a gap in the literature of which there is not a consensus
of information technology resource importance and feasibility for precision medicine in
healthcare delivery organizations. It is unsurprising that the literature does not contain an
established consensus given that the field of precision medicine is evolving. Information
technology resource importance and feasibility for precision medicine in healthcare
delivery organizations is still open for debate in the literature. My intention with this
study was to add to the debate by providing a new viewpoint.
The need for this study extends beyond there being a gap in the literature. An
important reason I conducted this study is that people have incomplete information to use
when making decisions regarding information technology resources for precision
medicine in healthcare delivery organizations. Information technology resource
requirements for precision medicine in healthcare delivery organizations are
undetermined considering that the field of precision medicine is emerging. There are a
wealth of new discoveries and a variety of applications in the field of precision medicine.
The need for this study stems from the fact that people have limited information to use
when making information technology resource decisions for precision medicine in
healthcare delivery organizations, which is evident by there being a gap in the literature.
Problem Statement
Millions of opportunities are missed each year to use precision medicine to
prevent patient harm (Caraballo, Bielinski, et al., 2017). The drug warfarin provides an
example of evidence indicating that it is possible to prevent patient harm using precision
medicine (Chan et al., 2016). Warfarin is a noteworthy example considering that in 1 year
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at least 2,000,000 people in the United States begin warfarin treatment and up to 20% of
them may be hospitalized due to patient harm (Alessandrini et al., 2016). The general
management problem was that healthcare delivery organizations underutilize information
technology resources for precision medicine which can lead to adverse effects on the
quality of patient care (Caraballo, Bielinski, et al., 2017). Information technology
resources lacking vital characteristics may exacerbate the problem. For instance, several
reports suggest that commercially available information technology products are not
mature in terms of meeting the requirements for precision medicine in healthcare delivery
organizations (Hoffman et al., 2016; Warner, Rioth, et al., 2016). Additionally, reports
indicate there is a shortage of information specialists with the skills necessary to
implement precision medicine (Gómez-López et al., 2019; Hulsen et al., 2019).
Billions of dollars are being invested in precision medicine globally (Feero, 2017;
Ginsburg & Phillips, 2018). Healthcare delivery organizations require the appropriate
information technology resources to take full advantage of the substantial investments in
precision medicine. The specific management problem was that people have limited
information to use when making decisions regarding information technology resources
for precision medicine in healthcare delivery organizations given the emerging state of
precision medicine. Support for there being limited information is that the literature does
not contain a consensus of information technology resource importance and feasibility for
precision medicine in healthcare delivery organizations. In addition to a gap in the
literature, reports suggest that healthcare delivery organizations have made ill-informed
decisions regarding potential information technology resource requirements for precision
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medicine. For instance, Caraballo, Hodge, et al. (2017) explained that the longevity of
early precision medicine information technology implementations is questionable due to
scalability concerns. Additionally, several reports indicate that data storage approaches
used in early precision medicine implementations may be insufficient for the long term
(Danahey et al., 2017; Hicks, Dunnenberger, et al., 2016).
Literature Gap
A noteworthy gap in knowledge exists in that the literature does not contain a
consensus of information technology resource importance and feasibility for precision
medicine in healthcare delivery organizations. The lack of agreement is apparent when
considering multiple views present in the literature. For example, Gómez-López et al.
(2019) discussed that a type of information specialist known as a clinical
bioinformatician is required to effectively implement precision medicine in healthcare
delivery organizations, but clinical bioinformaticians are rare. Caraballo, Hodge, et al.
(2017) explained that commercial electronic health record systems and clinical decision
support are essential to implement a type of precision medicine in a clinical setting, but
the systems may not handle near future increases in data. Danahey et al. (2017) discussed
that having the capability to integrate multiple data sources was essential to implement a
form precision medicine at a university affiliated healthcare delivery organization, but the
implementation involved custom building a sophisticated software system using several
specialty resources. The literature does not contain a consensus of information
technology resource importance and feasibility for precision medicine in healthcare
delivery organizations.
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Purpose of the Study
The purpose of this classical Delphi study was to determine how a panel of
precision medicine information technology experts view information technology resource
importance and feasibility for precision medicine in healthcare delivery organizations.
Determining a consensus of information technology resource importance and feasibility
may help address the problem of people having limited information when making
information technology resource decisions for precision medicine in healthcare delivery
organizations. The information gathered from the participants could help make future
information technology resource requirements less unclear. This Delphi study could
provide information that aids people in making sound information technology resource
decisions for precision medicine in healthcare delivery organizations.
Research Questions
Overarching research question: How does a panel of precision medicine
information technology experts view information technology resource importance and
feasibility for precision medicine in healthcare delivery organizations?
Subquestion 1: How does a panel of precision medicine information technology
experts view information technology resource importance for precision medicine in
healthcare delivery organizations?
Subquestion 2: How does a panel of precision medicine information technology
experts view information technology resource feasibility for precision medicine in
healthcare delivery organizations?
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Conceptual Framework
I used the resource-based view of the firm as the conceptual lens for this study
and is further described in Chapter 2. According to Lockett et al. (2008), the work of
Wernerfelt (1984) is the seminal article regarding the resource-based view of the firm.
Wernerfelt (1984) explained that a central concept in a resource-based view is company
resources, which include any tangible or intangible company assets. Resources can be
classified as physical resources, human resources, or organizational resources (Barney,
1991). I included each of the three resource categories in this study. Equipment, a
person’s intelligence, and a company’s reporting structure are examples of a physical
resource, human resource, and organizational resource, respectively (Barney, 1991). I
centered this study around the concept of company resources.
In a resource-based view, the concept of an organizational capability is a special
type of organizational resource that has distinctive features (Grant, 1991; Makadok,
2001). The main purpose of an organizational capability is to make other resources more
productive (Amit & Schoemaker, 1993; Makadok, 2001). An organizational capability is
built internally and embedded within a company (Amit & Schoemaker, 1993; Grant,
1991). I distinguish organizational capabilities from other types of resources in this study.
According to Makadok (2001), an example of an organizational capability is the internal
development of Walmart’s logistics system which improves the productivity of other
resources including real estate, trucks, personnel, and technology. The features of an
organizational capability distinguish it from other types of resources.
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Organizational capabilities and other types of resources are often discussed in the
literature as being associated with the concept of economic rents (Grant, 1991; Makadok,
2001). The concept of economic rents refers to potential above normal earnings that are
sustained (Conner, 1991). In a resource-based view, the term economic rents is used
interchangeably with the term competitive advantage (Barney, 2001). This study included
assessing information technology resource importance as a proxy for the concept of
economic rents.
In theory, certain resource characteristics are more likely than others to result in
economic rents (Amit & Schoemaker, 1993; Conner, 1991). Ideal resources have the
characteristics of being valuable and rare, and cannot be perfectly imitated or substituted
(Barney, 1991). This study included assessing information technology resource
importance as a substitute for the resource characteristic of being valuable. In addition,
this study involved assessing information technology resource feasibility which
represents the inverse of three resource characteristics that are being rare, imperfectly
imitable, and nonsubstitutable. Information technology resource importance and
feasibility are key features of the research questions. This study entailed assessing
information technology resource importance and feasibility to represent resource
characteristics associated with economic rents.
Nature of the Study
I selected the qualitative research method for this study based on its being well
suited to address the research questions. According to Williams (2007), a researcher
selects the research method according to the type of data most appropriate for responding
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to the research questions. Williams (2007) also mentioned that researchers can use a
qualitative method to understand details in situations that are complex. Similarly, Ravitch
and Carl (2016) explained that qualitative research is descriptive and fitting when
pursuing complexity. Additionally, Woods et al. (2016) discussed that qualitative
research combines knowledge and understanding to make judgements regarding
circumstances. Addressing the research questions involved gathering assessment
information from knowledgeable people regarding a complex topic, which made a
qualitative method suitable for this study.
When considering the literature, a Delphi design was appropriate for this study
given that addressing the research questions involved assessing importance and feasibility
information regarding a complex topic that is evolving and has many unknowns.
According to Rikkonen and Tapio (2009), a Delphi design is appropriate for topics in
which changes in trends are probable. Additionally, Delbecq et al. (1975) and Linstone
and Turoff (2002) concurred that a Delphi design is fitting when there is incomplete
information regarding a situation. Furthermore, Linstone and Turoff (2002) offered the
view that a Delphi design allows a group of people to jointly address a complex problem
and is useful to assess the importance and feasibility of options. Linstone and Turoff
(2002) also explained that the need for a Delphi design can result from certain
characteristics, including when exact analytics are not suitable for working on a problem
or when the participants needed to examine a complex problem have not had prior
communication. In addition, Delbecq et al. (1975) discussed that a Delphi design can be
useful for planning activities regarding information technology. A Delphi design was
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well suited for this study in that addressing the research questions involved assessing
importance and feasibility information regarding a complex topic that is evolving and has
many unknowns.
I used nonprobability purposive sampling and supplemented it with snowball
sampling to form a sample. The criteria to participate in the study were that an individual:
(a) could describe cases illustrating good versus poor decisions regarding information
technology resources for precision medicine in healthcare delivery organizations, (b) had
a minimum of 3 years of professional experience dealing with information technology for
precision medicine in healthcare delivery, (c) could write fluently in English, (d) did not
have a personal or professional relationship with me, and (e) was at least 18 years old.
Sampling provided the means to identify a group of specialists that met certain criteria.
I performed data collection and analysis in three consecutive rounds. I used
open-ended questions to make the Round 1 questionnaire. I analyzed text data collected
during Round 1 using thematic analysis. I structured the Round 2 questionnaire so that
participants could rate the importance and feasibility of information technology resources
identified in Round 1 as well as optionally provide additional information technology
resources. I analyzed importance and feasibility ratings collected during Round 2 to
assess the level of agreement among the participants. I performed thematic analysis on
any additional information technology resources collected during Round 2. The structure
of the Round 3 questionnaire allowed participants to rate the importance and feasibility of
additional information technology resources identified during Round 2 as well as rerate
the importance and feasibility of information technology resources from Round 2 that did
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not have consensus of importance, feasibility, or both. Similar to the data analysis for
Round 2, I analyzed importance and feasibility ratings collected during Round 3 to assess
the level of agreement among the participants. I performed three consecutive rounds of
data collection and analysis.
Definitions
Big data: A large amount of diverse information (Auffray et al., 2016).
Clinical decision support: Computer software aimed at affecting the decisions
clinicians make about patients (Miller et al., 2015).
Electronic health record system: A computerized information resource for
healthcare workers regarding patients (Smolij & Dun, 2006).
Information technology: The use of computers to store, transfer, and process data
(Ekwonwune et al., 2017).
Precision medicine: The use of assorted data to enhance the accuracy of
healthcare (König et al., 2017).
Assumptions
I made several assumptions for this study that are attributable to the qualitative
Delphi study design and extensive use of literature. The first assumption was that I would
address the research questions in an objective manner by identifying concepts in the
collected data and by assessing the concepts according to the level of agreement among
the participants. The second assumption was that the data collected from the sample
participants represent the views of the larger population of experts knowledgeable about
information technology resources for precision medicine in healthcare delivery
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organizations. The third assumption was that participant responses to the questionnaires
represent reality. The fourth assumption was that participants could clearly articulate their
views in writing when completing questionnaires. The fifth assumption was that
information found in the literature was accurate. The assumptions that I made for this
study were necessary given the qualitative Delphi study design and reliance on the
literature.
Scope
In this study, I addressed the problem of people having limited information to use
when making decisions regarding information technology resources for precision
medicine in healthcare delivery organizations given the emerging state of precision
medicine. More specifically, the purpose of this classical Delphi study was to determine
how a panel of precision medicine information technology experts view information
technology resource importance and feasibility for precision medicine in healthcare
delivery organizations. I chose the specific focus based on how the study could enhance
practice, theory, and positive social change as discussed below.
Delimitations
The delimitations should be taken into account when considering transferability of
the study to other contexts. One delimitation was that the sample only included
individuals that could write fluently in English. Therefore, I excluded people not able to
write fluently in English. Another delimitation was that the resource-based view of the
firm served as the conceptual framework. Hence, I centered the study around the concept
of company resources. I reviewed but did not select other conceptual frameworks because
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the other frameworks were not well aligned with the purpose of this study. For instance, I
considered but did not select the strategic alignment model described by Henderson and
Venkatraman (1999) due to poor alignment with the study purpose. The boundaries of the
study should be considered when assessing the transferability of this study to other
contexts.
Limitations
A limitation was that this study was subject to self-selection bias in that the
sample was composed of specialists who chose to participate. Knowledgeable experts
may have opted not to participate in the study due to time constraints, indifference to the
study, or insufficient compensation. In addition to offering a modest monetary gift, I
partially addressed the first limitation by using questionnaires that did not require a
substantial amount of time to complete.
Another limitation was that I used a cross-sectional design rather than a
longitudinal design. A cross-sectional investigation is useful to analyze data for a specific
point in time (Babbie, 2017) and does not provide information on how time may be an
influence (Caruana et al., 2015). An example of the cross-sectional design limitation is
that, according to McCoy (2017) and Vogl et al. (2018), research participants’
perspectives may change over time. I partially addressed the second limitation by using a
process to form consensus among the study participants. A consensus approach may have
created a balanced perspective and incorporated persisting elements regarding the
research questions.
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A third limitation was that most participants stated they reside in the United
States. There are many differences in healthcare systems of other countries when
compared to healthcare in the United States. (Toth, 2016). The generalizability of the
study to countries not represented in the sample is unknown. Considering differences in
healthcare systems across different countries was beyond the scope of this study.
Significance of the Study
This study could contribute to practice, theory, and positive social change.
Possible benefits of this study could advance practice in terms of strategic planning,
prioritizing investment options, and assessing opportunities regarding information
technology resources for precision medicine in healthcare delivery organizations. This
study could lead to developments in theory regarding concepts of information technology
resource planning, conceptual models regarding the evolution of information technology
resources, and how the dynamics of information technology resources affect society. The
study results could lead to positive social change in terms of enabling progress toward
improved healthcare quality, informing information technology resource decisions, and
advancing the intellect of people. This study could lead to advances in practice, theory,
and positive social change.
Significance to Practice
The study results could contribute to improvements in practice. The results could
aid people in making strategic planning decisions regarding information technology
resources for precision medicine in healthcare delivery organizations. Additionally, the
study results could be insightful to people when prioritizing resource investment options.
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Furthermore, the results could be useful to people when assessing opportunities to create
new information technology resources for precision medicine in healthcare delivery
organizations. This study could lead to improvements in practice in multiple ways.
The study results could enable practitioners to be more efficient. Practitioners
could save time by using the list of information technology resources as a checklist of
resources to consider when making decisions regarding precision medicine in healthcare
delivery organizations. Additionally, the list of information technology resources could
be used by practitioners to consider information technology resources in an organized and
more complete way. Furthermore, the list of information technology resources could be
used by practitioners as a delegation aid when assigning tasks. There are multiple ways in
which the study results could enable practitioners to be more efficient.
Significance to Theory
The study results could accelerate developments in theory. Given the emerging
state of the field of precision medicine, the results could provide a new perspective to
advance concepts associated with information technology resource planning when future
circumstances are unclear. Additionally, having determined information technology
resource importance and feasibility, the study results could inform conceptual models
concerning the evolution of information technology resources for precision medicine.
Furthermore, the results could lead to a better understanding of how the dynamics of
information technology resources for precision medicine influence society. The study
results could contribute to different types of advancements in theory.
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Significance to Social Change
At a societal level, the study results could give rise to positive social change by
enabling progress toward improved healthcare quality using information technology
resources for precision medicine in healthcare delivery organizations. Information
technology resources for precision medicine are underutilized, which can lead to adverse
effects on the quality of healthcare (Caraballo, Bielinski, et al., 2017). Having created a
list of information technology resources considered important and feasible, the study
results could create a shared vision of what is needed to fulfill information technology
resource requirements for precision medicine in healthcare delivery organizations.
Creating a shared vision could lead to improved utilization of information technology
resources for precision medicine in healthcare delivery organizations as well as improved
healthcare quality. The study results could prompt positive social change at a societal
level by enabling progress toward improved healthcare quality.
In addition to positive social change at a societal level, the study results could
lead to positive social change at an organizational level by informing information
technology resource decisions for precision medicine in healthcare delivery
organizations. For instance, reports indicate there is a shortage of information specialists
with the skills necessary to implement precision medicine (Gómez-López et al., 2019;
Hulsen et al., 2019). Positive social change could result by educational organizations
considering the study results when making decisions about enhanced curricula targeted at
people who function as human information technology resources for precision medicine
in healthcare delivery organizations. Enhanced curricula may help alleviate the shortage
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of information specialists. As another example, multiple reports suggest that
commercially available information technology products are not mature in terms of
meeting the requirements for precision medicine in healthcare delivery organizations
(Hoffman et al., 2016; Warner, Rioth, et al., 2016). Positive social change could result by
commercial vendors considering the study results when making decisions about the
creation of new physical information technology resources that would meet the
requirements for precision medicine in healthcare delivery organizations. As a third
example, reports indicate that data storage approaches used in early precision medicine
implementations may be insufficient for the long term (Danahey et al., 2017; Hicks,
Dunnenberger, et al., 2016). Positive social change could result by healthcare delivery
organizations considering the study results when making decisions about the creation of
adaptable data storage solutions for precision medicine. Adaptability could help increase
the longevity of data storage solutions. The study results could lead to positive social
change by informing decisions made by organizations regarding information technology
resources for precision medicine in healthcare delivery organizations.
Besides positive social change at organizational and societal levels, the study
results may lead to positive social change at an individual level by advancing the intellect
of people. I conducted this study in part because the literature did not contain a consensus
of information technology resource importance and feasibility for precision medicine in
healthcare delivery organizations. Given that this study addresses a literature gap,
individuals that read this dissertation may benefit intellectually. The study results may
lead to positive social level change at an individual level.
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Summary and Transition
In sum, this study focused on information technology resources for precision
medicine in healthcare delivery organizations. Information technology resources are a
vital component for precision medicine in healthcare delivery organizations. Given that
precision medicine is an evolving field, information technology resource requirements
are undetermined for precision medicine in healthcare delivery organizations. People
have incomplete information to use when making decisions regarding information
technology resources for precision medicine in healthcare delivery organizations. This
study could provide information that aids people in making sound information
technology resource decisions for precision medicine in healthcare delivery
organizations. This study could advance practice in multiple ways. In addition, this study
could accelerate different types of theoretical advancements. Focusing on information
technology resources for precision medicine in healthcare delivery organizations could
benefit society.
Knowledge is advanced by building upon what is already known (Xiao &
Watson, 2019). Chapter 2 contains a synthesis of literature relevant to this study. The
discussion presented in Chapter 2 provides a foundation of knowledge for this study to
build upon.
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Chapter 2: Literature Review
The general management problem addressed in this study was that healthcare
delivery organizations underutilize information technology resources for precision
medicine which can lead to adverse effects on the quality of patient care (Caraballo,
Bielinski, et al., 2017). The specific management problem addressed was that people
have limited information to use when making decisions regarding information technology
resources for precision medicine in healthcare delivery organizations given the emerging
state of precision medicine. Support for there being limited information is that the
literature does not contain a consensus of information technology resource importance
and feasibility for precision medicine in healthcare delivery organizations. The purpose
of this classical Delphi study was to determine how a panel of precision medicine
information technology experts view information technology resource importance and
feasibility for precision medicine in healthcare delivery organizations.
The synthesis of literature presented in Chapter 2 provides a base of knowledge
for this study to build upon. I performed a thorough literature search and described the
method used in the literature search strategy section of this chapter. The conceptual
framework section includes a detailed review of the resource-based view of the firm as it
applies to this study. The literature review section includes an extensive review of
numerous topics relevant to this study beginning with a conceptual discussion of
precision medicine. The summary and conclusions section includes a synopsis of the
literature reviewed.
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Literature Search Strategy
I completed the literature search in an iterative manner. I performed initial
searches using broad keyword search terms, which I subsequently refined to focus on
more specific topics. I applied date filters to concentrate on contemporary literature. I
considered peer reviewed journal articles published within the past 5 years as a desirable
category of literature. I assessed the titles of literature returned in search results to
determine if the literature may be applicable to this study. I examined the full text of
literature in cases where I deemed the titles to be relevant to this study. I reviewed the
reference sections of literature relevant to this study to identify additional sources that
may not have appeared in search results. I used an iterative approach to search the
literature.
I performed the literature search using several online resources and keyword
search terms. I searched the literature using Google Scholar and several online databases
available through the Walden University library. The online databases included
ABI/INFORM Collection, Academic Search Complete, Business Source Complete,
Computers and Applied Sciences Complete, Emerald Insight, IEEE Xplore, ProQuest,
PubMed, SAGE Journals, and ScienceDirect. The keyword search terms included: big
data analytics capability, big data analytics healthcare, big data analytics value, clinical
decision support, Delphi, genomics clinical decision support, genomics electronic health
record, genomics technology, information technology Delphi, information technology
resources, personalized medicine, pharmacogenetics clinical decision support,
pharmacogenetics electronic health record, pharmacogenetics technology,
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pharmacogenomics clinical decision support, pharmacogenomics electronic health
record, pharmacogenomics technology, precision medicine, precision medicine adverse
drug reactions, precision medicine big data, precision medicine clinical decision support,
precision medicine electronic health record, precision medicine genomics, precision
medicine omics, precision medicine quality, precision medicine safety, precision
medicine technology, resource based view, resource based view Delphi, resource based
view technology, and stratified medicine. I used several online resources and keyword
search terms to complete the literature search.
Conceptual Framework
The resource-based view of the firm grounds this study conceptually. A
resource-based view focuses on internal company characteristics as opposed to external
industry factors (Amit & Schoemaker, 1993; Barney, 1991). Company resources are a
central concept in a resource-based view of the firm and include any tangible or
intangible company assets (Wernerfelt, 1984). In a resource-based view, a company can
be considered as a bundle of resources (Conner, 1991; Wernerfelt, 1984). In theory, the
way a company combines resources affects the company performance (Amit &
Schoemaker, 1993; Conner, 1991). Managers are tasked with renewing resources and
relationships among resources (Conner, 1991). I have centered this study around the
concept of company resources.
Differentiating types of resources helps bring clarity to the wide array of
resources companies have. Resources can be categorized as physical resources, human
resources, or organizational resources (Barney, 1991). In the context of information
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technology, physical resources are things used as part of an overall information
technology infrastructure (Bharadwaj, 2000). Examples of physical information
technology resources include computers, digital networks, software, and electronic data
(Aral & Weill, 2007; Bharadwaj, 2000). Human resources, in the context of information
technology, are the technical and managerial skills and knowledge of people (Bharadwaj,
2000). Examples of human information technology resources include technical and
managerial competencies in information systems analysis and design, software
programming, and emerging technology (Bharadwaj, 2000). Organizational resources are
managerial focused and used to affect how people interact (Diin et al., 2018). Examples
of organizational resources include methods of reporting, planning, coordinating, and
controlling (Barney, 1991). This study included distinguishing resource categories to help
bring clarity to the assortment of information technology resources for precision
medicine in healthcare delivery organizations.
A special type of organizational resource is an organizational capability
(Makadok, 2001). The concept of an organizational capability is the ability to perform an
activity using multiple resources (Grant, 1991). The main purpose of an organizational
capability is to make other resources more productive (Makadok, 2001). An
organizational capability is built internally and embedded within a company (Grant,
1991; Makadok, 2001). The development of an organizational capability occurs gradually
through experience and typically involves information-based processes (Amit &
Schoemaker, 1993; Grant, 1991). Given that organizational capabilities are a special type
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of organizational resource, I distinguished them from other types of resources in this
study.
In the context of information technology, organizational capabilities may exist in
multiple areas (Wade & Hulland, 2004). Three examples of information technology
capability areas are integrating information technology with the business, designing
information technology architecture, and delivering information technology services
(Wade & Hulland, 2004). In a discussion of information technology resource
characteristics Bharadwaj (2000) provided an example of a company that had information
technology capabilities in multiple areas. First, Bharadwaj (2000) explained that the
company’s information technology personnel are able to envision the business benefits of
creating a new application, which denotes the capability area of integrating information
technology with the business. Second, Bharadwaj (2000) discussed the flexibility of the
company’s information technology infrastructure, which denotes the capability area of
designing information technology architecture. Third, Bharadwaj (2000) explained that a
new information technology application for the company could be delivered in a short
time frame, which denotes the capability area of delivering information technology
services. Organizational capabilities regarding information technology can exist in
multiple areas.
Information technology capabilities and other types of information technology
resources may be associated with the concept of economic rents (Bharadwaj, 2000; Wade
& Hulland, 2004). The concept of economic rents refers to potential above normal
earnings that are sustained (Conner, 1991). In a resource-based view, the term economic
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rents is used interchangeably with the term competitive advantage (Barney, 2001). This
study included assessing information technology resource importance as a proxy for the
concept of economic rents.
In theory, resources that are valuable, rare, imperfectly imitable, and
nonsubstitutable are potential sources of economic rents (Barney, 1991). This study
included assessing information technology resource importance as a substitute for the
characteristic of being valuable. This study also included assessing information
technology resource feasibility which represents the inverse of three resource
characteristics that are being rare, imperfectly imitable, and nonsubstitutable. This study
included assessing information technology resource importance and feasibility to
represent resource characteristics associated with economic rents.
According to Mata et al. (1995), managerial information technology skills are an
example of a resource that is a possible source of economic rents. The resource
characteristic of being valuable can be recognized in the article by Mata et al. (1995)
when the authors discussed that managerial information technology skills, such as the
ability to understand a company’s business needs, are valuable in achieving the full
benefits of information technology. The resource characteristic of being rare can be
recognized in the article by Mata et al. (1995) when the authors discussed that developing
managerial information technology skills depends on close relationships that may be rare
between information technology personnel and personnel working in other areas of a
company. The resource characteristic of being imperfectly imitable can be recognized in
the article by Mata et al. (1995) when the authors discussed that tacit managerial
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information technology skills that cannot be codified may involve countless decisions
that are imperfectly imitable. The resource characteristic of being nonsubstitutable can be
recognized in the article by Mata et al. (1995) when the authors discussed that managerial
information technology skills may be nonsubstitutable when they are immobile and
embedded within a company. Managerial information technology skills provide an
example of a resource that is a potential source of economic rents.
Some resources may become a source of economic rents when combined with
other resources. Barney (1991) discussed physical technology resources as an example of
resources that are not usually a source of economic rents. Physical technology resources
are generally imitable (Barney, 1991). Physical technology resources may become a
source of economic rents when combined with socially complex resources that are
valuable, rare, imperfectly imitable, and nonsubstitutable (Barney, 1991). The
combination of physical technology resources and socially complex resources may allow
a company to more fully exploit physical technology resources (Barney, 1991).
Combining resources may create a source of economic rents.
In sum, I centered this study around the concept of company resources. This study
included distinguishing between physical, human, and organizational resources. Given
that organizational capabilities are a special type of organizational resource, I
distinguished them from other types of resources in this study. This study included
assessing information technology resource importance and feasibility to represent the
concept of economic rents and resource characteristics associated with economic rents.
The resource-based view of the firm grounded this study conceptually.
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Literature Review
Precision medicine can be characterized as a paradigm shift not unlike others that
have occurred in history of healthcare. According to Fernandes et al. (2017), a paradigm
shift is a change in basic concepts and practices of a scientific field. In a conceptual
debate of precision medicine, Vegter (2018) explained that paradigm shifts in the history
of healthcare include a shift toward using technology to improve diagnostics, a shift
toward using statistics to define an illness as a deviation from the norm, and a shift
toward widespread access to healthcare information. Precision medicine is a shift toward
using a variety of data types to continually improve the accuracy of healthcare (König et
al., 2017; Vegter, 2018). In a similar view, Tebani et al. (2016) discussed that precision
medicine is a shift to provide more customized and accurate healthcare by incorporating a
constantly improved understanding of biology based on a variety of measurements.
Additionally, Prosperi et al. (2018) explained that the precision medicine paradigm
involves using detailed patient information to make more accurate predictions in care.
Furthermore, according to Ginsburg and Phillips (2018), precision medicine entails a
shift from treatment to the prevention of disease. Precision medicine is a paradigm shift
that builds on earlier advancements in healthcare knowledge (Vegter, 2018).
The paradigm shift associated with precision medicine has led to the formation of
a complex field combining a variety of sophisticated topics. Researchers have addressed
several complex topics regarding the field of precision medicine. For instance, in addition
to discussing the complementary relationship between reductionist and integrative
approaches to studying health issues Beckmann and Lew (2016) explained that the
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confluence of three disruptive forces affect precision medicine. According to Beckmann
and Lew (2016), the disruptive forces include revolutionary advancements in high
resolution data generating technology, innovative high speed computation capacities in
information science, and the expansion of patient empowerment due to social media and
the use of connected electronic devices. In another case of complex topics, Huang et al.
(2016) explained that collaborative efforts are needed to implement several features of
precision medicine and that some factors affecting precision medicine include big data
analytics, training, financial models, quality control, and regulation. Vegter (2018) added
to the list of sophisticated topics associated with precision medicine when discussing the
profile of precision medicine which includes epistemological, bio-political, and ethical
considerations. Vegter (2018) concluded the discussion by providing the view that the
profile of precision medicine is differentiated by a focus on issues associated with
prediction and prevention.
As part of describing the profile of precision medicine, Vegter (2018) claimed
that big data science provides an epistemological base for precision medicine. There is
general agreement that data analytics is a vital component of precision medicine. After
clarifying that the terms precision medicine and personalized medicine are used
interchangeably, Fröhlich et al. (2018) explained that precision medicine stems from a
base of data science. According to Fröhlich et al. (2018), analyzing data from multiple
sources provides a better understanding of a patient and is the key to making clinically
useful predictions for precision medicine. Similarly, Prosperi et al. (2018) indicated that
precision medicine is based on analyzing data from a variety of sources. In addition,
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Vegter (2018) claimed that data mirror the truth about a person’s health and that an aim
of precision medicine is to analyze every quantifiable aspect.
Even though there is general agreement that data analytics is an essential
component of precision medicine, the emerging focus of precision medicine efforts
continues to be debated. According to Vegter (2018), the focus of precision medicine
efforts is still maturing, and some believe that precision medicine research should be at
the intersection of a person’s biology, lifestyle, and environment. In addition, Intille
(2016) explained that the details of a national precision medicine research initiative are
under development but may include investigating health factors associated with genetics,
sleep, and pollution. In a review of precision medicine efforts around the globe, Lee et al.
(2019) added to the debate by suggesting that there is a lack of longitudinal designs in
precision medicine efforts given that time is a factor when assessing changes in health. In
another view, Lau and Wu (2018) suggested that the basic question for precision
medicine involves understanding how peoples’ genomes and life histories affect
wellbeing, probability of disease, and response to treatment. In the context of oncology,
Kensler et al. (2016) provided support for the idea that precision medicine has a
transformative role in the prevention of disease. According to Pasipoularides (2018), a
focus of precision medicine in the context of cardiology is understanding relationships
between genomics and disease. In the context of psychiatry, Fernandes et al. (2017)
suggested the precision medicine can aid in matters of diagnosis, treatment, and
prognosis. The debate regarding the emerging focus of precision medicine efforts
continues.
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Considering the emerging focus of precision medicine efforts, it is not surprising
that healthcare delivery organizations are in early stages of applying precision medicine.
The literature contains several cases of early applications of precision medicine in
healthcare delivery organizations and a few of those cases are discussed here. In a case
discussed by Arnall et al. (2019), as part of a newly formed precision medicine program,
an academic cancer center conducted a pilot project to define the role of clinical
pharmacy services for precision medicine. In another case, Fiore et al. (2016) discussed a
pilot project for precision medicine and explained that a national government healthcare
delivery organization demonstrated feasibility of incorporating precision medicine with
clinical care in an oncology context focusing on military veterans with lung cancer. In a
different case, according to Dunnenberger et al. (2016), a university affiliated health
system developed a pharmacogenomics clinic and made adjustments to improve
utilization after the clinic opened. In a different case, Dressler et al. (2018) explained that
an integrated health system conducted a series of pilot research studies to aid in the
development of an outpatient precision medicine clinic for the provision of
pharmacogenomic services. Healthcare delivery organizations are in the early phases of
using precision medicine.
Besides being in the early phases of using precision medicine, healthcare delivery
organizations use complex and specialized resources for precision medicine. For instance,
according to Nadauld et al. (2018), an academic medical center developed an in-house
genomic test to analyze over 100 clinically relevant genes for precision medicine in an
oncology context. Nadauld et al. (2018) also explained that the organization periodically

31
considers modifying the genomic test to incorporate new discoveries and uses knowledge
of molecular pathology fellows to help decide when modifications to the test are
warranted. In another case, according to Walko et al. (2016), a cancer center uses a
specialized committee to assist in interpreting genomic information for precision
medicine. Walko et al. (2016) also discussed that the committee consists of a diverse
group of experts including information specialists, financial strategists, basic scientists,
translational scientists, molecular pathologists, oncologists, pharmacists, nurses, and
genetic counselors. Walko et al. (2016) further explained that the committee reviews a
patient case by considering the findings from a full literature review and the personal,
clinical, and genomic characteristics of the patient. Healthcare delivery organizations use
complex and specialized resources for precision medicine.
In addition to using complex and specialized resources for precision medicine,
healthcare delivery organizations use information technology to facilitate precision
medicine. According to Beckmann and Lew (2016), specialized information technology
facilitates the clinical use of complex multiscale and multilevel data sets for precision
medicine. In addition, Danahey et al. (2017) discussed that a university affiliated
healthcare delivery organization uses information technology to condense information
from thousands of literature sources into summaries that healthcare workers can use as an
aid when making medication prescribing decisions for precision medicine. According to
Danahey et al. (2017), the information technology solution involved building a clinical
decision support system to simplify the clinical practice of precision medicine. Danahey
et al. (2017) also explained that the summaries are displayed with links to primary

32
literature sources. A different case discussed by Dressler et al. (2018) is in the context of
integrating clinical decision support with clinical processes for pharmacogenomics,
which is a form of precision medicine. According to Dressler et al. (2018), an integrated
health system uses information technology to automatically analyze multiple patient data
elements and deliver patient specific advice to healthcare workers to promote patient
safety regarding medications. Information technology facilitates precision medicine in
healthcare delivery organizations.
Given the use of information technology for precision medicine, a noteworthy gap
in knowledge exists in that the literature does not contain a consensus of information
technology resource importance and feasibility for precision medicine in healthcare
delivery organizations. The lack of agreement is apparent when considering multiple
views present in the literature. Here are a few examples. In one view, Gómez-López et al.
(2019) discussed that a type of information specialist known as a clinical
bioinformatician is required to effectively implement precision medicine in healthcare
delivery organizations, but clinical bioinformaticians are rare. In a different view,
Caraballo, Hodge, et al. (2017) explained that commercial electronic health record
systems and clinical decision support are essential to implement a type of precision
medicine in a clinical setting, but the systems may not handle near future increases in
data. In another view, Danahey et al. (2017) discussed that having the capability to
integrate multiple data sources was essential to implement a form precision medicine at a
university affiliated healthcare delivery organization, but the implementation involved
custom building a sophisticated software system using several specialty resources. The
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literature does not contain a consensus of information technology resource importance
and feasibility for precision medicine in healthcare delivery organizations.
A Delphi design provides useful methods to address topics concerning
information technology resources when knowledge is incomplete. Delbecq et al. (1975)
and Linstone and Turoff (2002) agreed that a Delphi design is suitable when there is
incomplete information regarding a situation. Similarly, according to Skulmoski et al.
(2007), a Delphi design is appropriate when there is incomplete knowledge about a
problem and a researcher seeks to enhance an understanding of solutions using the
judgment of experts. In one case of using a Delphi design Duncan (1995) addressed a
situation of incomplete knowledge using a Delphi questionnaire to collect data from
information technology executives about the importance of information technology
resource characteristics regarding infrastructure flexibility. In another case, Niederman et
al. (1991) conducted a three round Delphi study with information technology executives
to understand the most important information technology management issues, which
consequently are most deserving of resource investment. Researchers have used Delphi
methods to enhance knowledge on topics regarding information technology resources.
Researchers have used Delphi methods to examine topics regarding information
technology resources for data analytics. For instance, Akter et al. (2016) conducted a two
round Delphi study and used themes in the collected data to identify 11 subdimensions of
a big data analytics capability, which is considered an organizational information
technology resource in a resource-based view. Similarly, Ranko et al. (2015) conducted a
study using Delphi methods to advance a conceptual business analytics capability
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framework which expert participants helped refine by providing input regarding the
structure, definitions, and relative importance of components. In another study, CôrteReal et al. (2019) used Delphi methods to identify and rank 23 company level
antecedents of business value generated using big data analytics. Several of the
antecedents identified by Côrte-Real et al. (2019) can be categorized as organizational
information technology resources including managerial capabilities, analytical
capabilities, dynamic capabilities, and an analytical decision making culture. Another
antecedent that Côrte-Real et al. (2019) called big data analytics applications can be
categorized as a physical information technology resource. In a different article, Vidgen
et al. (2017) discussed how Delphi methods were used to identify 31 organizational
challenges regarding the use of big data analytics to generate business value and to reach
a consensus of how the challenges rank in terms of importance. Organizations can use the
list of challenges produced by Vidgen et al. (2017) as a checklist when building a
business analytics capability. Researchers have examined topics regarding information
technology resources for data analytics using Delphi methods.
In sum, a discussion of the literature regarding this study provides a variety of
relevant points to consider. Precision medicine is a paradigm shift that builds on earlier
advancements in healthcare knowledge which has led to the formation of a complex field
combining a variety of sophisticated topics. Even though there is general agreement that
data analytics is an essential component of precision medicine, the emerging focus of
precision medicine efforts continues to be debated. Precision medicine practices are being
incorporated in healthcare delivery organizations using complex resources, specialized
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resources, and information technology resources. Given the prevalent use of information
technology for precision medicine, a noteworthy gap in knowledge exists in that the
literature does not contain a consensus of information technology resource importance
and feasibility for precision medicine in healthcare delivery organizations. Previous
researchers have used Delphi methods to examine topics concerning information
technology resources. There is an assortment of considerations relevant to this study.
Information Delivery
The topic of information delivery is central to healthcare delivery organizations.
Information delivery is essential to clinical, administrative, and operational processes in
healthcare delivery organizations. The ability of a healthcare delivery organization to
save the life of a patient may depend on the speed and accuracy of information delivery.
Information delivery is a common topic in reports of precision medicine in healthcare
delivery organizations. Several reports provide useful information about physical, human,
and organizational forms of information technology resources used in information
delivery for precision medicine. The following discussion is based on several early cases
of precision medicine in healthcare delivery organizations that include discussion about
information technology.
One theme that stands out in the literature is that information technology enhances
information delivery for precision medicine in healthcare delivery organizations. For
instance, according to Caraballo, Bielinski, et al. (2017), a multistate healthcare
institution uses clinical decision support pop-up alert messages in an electronic health
record system to automatically deliver sophisticated information quickly and provide
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advice to enable precision medicine. Similarly, Dressler et al. (2018) discussed a case in
which a community health system uses pop-up alert messages in an electronic health
record system to disseminate changes to patient safety policies across the organization for
precision medicine. Additionally, Luzum et al. (2017) explained that the use of
information technology to disseminate information for precision medicine to a
widespread audience occurs in multiple healthcare delivery organizations using online
sites. Healthcare delivery organizations use information technology to enhance
information delivery for precision medicine.
In addition to being enhanced using information technology, information delivery
for precision medicine in healthcare delivery organizations is performed through multiple
channels. In a study that included survey methods to collect data regarding the
implementation of genomic information resources, Rasmussen et al. (2016) explained
that healthcare delivery organizations use several physical forms of information
technology resources to deliver information for precision medicine. The physical
information technology resources provided by Rasmussen et al. (2016) included
electronic health record systems, content management systems, compliance education
systems, personal health records, email, and websites. Similarly, in a study that included
multiple case study methods to investigate the implementation of genomics in clinical
practice, Sperber et al. (2017) explained that healthcare delivery organizations deliver
information for precision medicine using numerous physical forms of information
technology resources. More specifically, the physical information technology resources
provided by Sperber et al. (2017) included electronic health record systems, patient
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portals containing health information, clinical decision support, best practice alerts, data
warehouses, websites, online education modules, and online newsletters. Additionally,
other channels to deliver information for precision medicine include printed handouts,
faxes, and hard copies delivered in the mail (Danahey et al., 2017; Warner, Jain, et al.,
2016). Healthcare delivery organizations use multiple channels to deliver information for
precision medicine.
Healthcare delivery organizations not only use multiple channels, but also
incorporate multiple information sources in information delivery practices for precision
medicine. For instance, according to Herr et al. (2019), healthcare delivery organizations
obtain recommendations for precision medicine from government agencies and specialty
consortiums for use in delivering pharmacogenomic information using clinical decision
support. Shifting to specific cases, Manzi et al. (2017) provided an account in which a
pediatric teaching hospital uses primary literature articles and specialty consortiums as
sources of information to make decisions regarding the delivery of pharmacogenomic
information using clinical decision support for precision medicine. Similarly, Danahey et
al. (2017) explained that a university affiliated healthcare delivery organization utilizes
information from government agencies, specialty consortiums, and literature articles in
the delivery of syntheses of information for precision medicine. Interestingly, Mukerjee
et al. (2018) addressed a noteworthy consideration when using multiple information
sources by explaining that discrepancies have been identified among different
information sources for precision medicine. Information delivery practices for precision
medicine in healthcare delivery organizations include multiple information sources.
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As well as using multiple information sources, healthcare delivery organizations
use electronic health record systems in a vital role to deliver information for precision
medicine. According to Sperber et al. (2017), electronic health record systems are
foundational to delivering information in the patient care process for precision medicine.
Similarly, in the context of establishing precision medicine in healthcare delivery
organizations Arwood et al. (2016) explained that delivering accurate and timely
information for precision medicine is only feasible when using an electronic health record
system. Reports of healthcare delivery organizations using electronic health record
systems to deliver information for precision medicine are common. In fact, several
reports describe how electronic health record systems are used to deliver
pharmacogenomic information to healthcare workers (Hicks, Stowe, et al., 2016;
Rosenman et al., 2017). Electronic health record systems are physical information
technology resources that have a key role in information delivery for precision medicine
in healthcare delivery organizations.
Besides using electronic health record systems in a vital role, healthcare delivery
organizations adapt electronic health record systems to deliver information for precision
medicine. According to Hicks, Stowe, et al. (2016), healthcare delivery organizations are
required to customize the infrastructure of an electronic health record system for
precision medicine. Additionally, Ohno-Machado et al. (2018) explained that healthcare
delivery organizations deliver genomic information as allergies, clinical problems, and
lab results depending on the implementation of the electronic health record system.
Furthermore, healthcare delivery organizations deliver notifications for precision
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medicine within an electronic health record system using either clinical notes or inbox
messages depending on the system implementation (Caraballo, Hodge, et al., 2017;
Sperber et al., 2017). Hicks, Stowe, et al. (2016) provided an account of using an
electronic health record system to deliver pharmacogenomic information. According to
Hicks, Stowe, et al. (2016), the delivery of information for precision medicine at a
multistate health system can be affected by the medications prescribed to a patient, the
documentation of genomic information, and the reasons provided when healthcare
workers acknowledge recommendations. Rasmussen et al. (2016) provided a discussion
of customizing the delivery of genomic information for healthcare delivery organizations.
Interestingly, according to Rasmussen et al. (2016), an area of opportunity for vendors of
electronic health record systems is offering the ability to deliver information from
external sources while allowing for local adaptation. Healthcare delivery organizations
deliver information for precision medicine by adapting electronic health record systems.
In addition to adapting electronic health record systems, healthcare delivery
organizations use information technology resources in specialized ways for information
delivery due to the emerging state of precision medicine. For instance, according to
Sperber et al. (2017), a university medical center uses a pharmacogenomics group to
oversee the portions of patient test results considered clinically relevant, which are
delivered using an electronic health record system. Sperber et al. (2017) also explained
that portions of patient test results not considered clinically relevant are not stored in the
electronic health record system but may later be moved into the electronic health record
system if the emerging literature suggests clinical relevance. Similarly, Danahey et al.
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(2017) described an account in which a university affiliated healthcare delivery
organization only delivers portions of patient test results using clinical decision support
that a group of people deem clinically relevant. According to Danahey et al. (2017),
portions of test results not considered clinically relevant are stored in a non-production
information technology environment for later consideration based on emerging literature.
Because the field of precision medicine is emerging, healthcare delivery organizations
deliver information for precision medicine using information technology resources in
specialized ways.
The emerging literature regarding information delivery in healthcare delivery
organizations for precision medicine regularly contains descriptions of the differences
between passive and active forms of clinical decision support. According to Hicks et al.
(2019), passive forms of clinical decision support remain in the background waiting for
an end user to make a selection. In contrast to passive forms, Manzi et al. (2017)
explained that active forms of clinical decision support tend to be interruptive and
automatic. Delivering information to aid a healthcare worker in making a medication
prescribing decision using clinical decision support provides a case that is useful to
illustrate both the passive and active forms of clinical decision support. In a study of how
clinical decision support impacts medication prescribing behaviors for precision
medicine, O'Donnell et al. (2017) described an example of the passive form of clinical
decision support in which a healthcare worker must deliberately access information used
to aid in making a medication prescribing decision through a standalone web portal
requiring a separate login. In contrast, Hicks et al. (2019) provided an example of an
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active form of clinical decision support in which a message pops up in an electronic
health record system that interrupts the workflow of a healthcare worker to aid in making
medication prescribing decisions. The differences between passive and active forms of
clinical decision support are regularly described in reports regarding information delivery
in healthcare delivery organizations for precision medicine.
As well as using different forms of clinical decision support, healthcare delivery
organizations use clinical decision support alerts in different ways to deliver information
for precision medicine. According to Sperber et al. (2017), there is a lack of standard
methods for healthcare delivery organizations to create clinical decision support alerts for
the delivery of precision medicine information. Similarly, Herr et al. (2019) discussed
that the use of clinical decision support alerts to deliver information for precision
medicine is not standard and can be affected by the expertise of information specialists,
the functionality of electronic health record systems, and funding. Herr et al. (2019) also
explained that healthcare delivery organizations vary the timing and use of dynamic
versus static text in clinical decision support alerts for precision medicine. Shifting to
specific cases, Manzi et al. (2017) described an account in which a children’s hospital
adapted clinical decision support alerts that were provided by another healthcare delivery
organization that has a different clinical setting. According to Manzi et al. (2017), the
children’s hospital uses the alerts at varied times in the provision of precision medicine
services to deliver information for preventive purposes. In another case, Hicks, Stowe, et
al. (2016) explained that a multistate health system uses custom alerts to deliver
information for precision medicine including guidance for patient testing,
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recommendations for prescribing medications, and links to supplemental information.
Similarly, according to Sperber et al. (2017), a healthcare delivery organization uses
alerts to deliver precision medicine information including patient test results, test result
significance, suggested actions, and links to supplemental information. Healthcare
delivery organizations use clinical decision support alerts in assorted ways to deliver
information for precision medicine.
Besides using clinical decision support alerts, healthcare delivery organizations
regularly use online sites to deliver information for precision medicine. According to
Rasmussen et al. (2016), several healthcare delivery organizations deliver genomic
information for precision medicine using online sites. Similarly, Luzum et al. (2017)
explained that several healthcare delivery organizations use online sites to deliver an
assortment of materials for precision medicine including videos, presentations,
publications, continuing education, information about genomic services, supplemental
information for clinical decision support, and newsletters summarizing journal articles
relevant to healthcare workers. Interestingly, in a discussion of controlling the delivery of
information for precision medicine, Rasmussen et al. (2016) made a distinction between
local and remote hosting by explaining that healthcare delivery organizations deliver
information that is under control of the healthcare delivery organization and also deliver
information that is under the control of another organization. Healthcare delivery
organizations regularly deliver information for precision medicine using online sites.
In addition to using online sites, healthcare delivery organizations develop custom
software applications to deliver information for precision medicine. For instance,
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according to Aronson et al. (2016), an academic medical center developed a custom
software application to deliver patient test results to healthcare workers for precision
medicine. Similarly, Danahey et al. (2017) explained that a university affiliated
healthcare delivery organization coordinated physical, human, and organizational forms
of information technology resources to develop and monitor a custom software
application used to deliver information indicating if medications could have undesirable
affects based on inherited genomes. As is evident by the cases discussed, information
delivery for precision medicine in healthcare delivery organizations can involve the
development of custom software applications using multiple forms of information
technology resources.
Healthcare delivery organizations not only use human and organizational forms of
information technology resources in software development activities, but also in
information delivery oversight activities for precision medicine. For instance, Manzi et al.
(2017) provided an account in which a pediatric teaching hospital uses information
specialists to serve on a pharmacogenomics committee to direct the delivery of
information for precision medicine. Similarly, in the supplemental material of an article
on developing clinical pharmacogenomics, Hicks, Stowe, et al. (2016) explained that a
large health system uses a committee to review the language to be delivered in clinical
decision support alerts for precision medicine. Information specialists and committees
represent human and organizational forms of information technology resources that
healthcare delivery organizations use in information delivery oversight activities for
precision medicine.
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As well as oversight activities, healthcare delivery organizations use information
technology resources in maintenance activities for information delivery due to the
emerging state of precision medicine. For instance, according to Danahey et al. (2017),
the delivery of clinical decision support information in a university affiliated healthcare
delivery organization involves the use of an automated query mechanism to identify new
literature sources that may lead to altering the delivery of information for precision
medicine. As another example, Caraballo, Bielinski, et al. (2017) provided a case in
which clinical decision support within an electronic health record system is used to
deliver pharmacogenomic information for precision medicine. Caraballo, Bielinski, et al.
(2017) explained that a multistate healthcare delivery organization experiences
noteworthy maintenance issues for clinical decision support due to changes in published
guidelines. According to Caraballo, Bielinski, et al. (2017), clinically relevant genomic
discoveries, dynamic genomic interpretations, and changes in nomenclature are factors to
consider regarding maintenance of information delivery. Given that the field of precision
medicine is emerging, healthcare delivery organizations use information technology
resources for the maintenance of information delivery.
In sum, there is an assortment of relevant aspects to consider regarding
information technology resources used in healthcare delivery organizations to deliver
information for precision medicine. Information technology enhances information
delivery for precision medicine in healthcare delivery organizations. Healthcare delivery
organizations use physical, human, and organizational forms of information technology
resources to deliver information for precision medicine. Healthcare delivery
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organizations use multiple information sources and multiple channels in information
delivery practices for precision medicine. Healthcare delivery organizations commonly
use online sites, electronic health record systems, and clinical decision support alerts to
deliver information for precision medicine. Due to the emerging state of precision
medicine, healthcare delivery organizations oftentimes use information technology
resources in specialized ways for information delivery. Healthcare delivery organizations
develop custom software applications and adapt electronic health record systems to
deliver information for precision medicine. Healthcare delivery organizations use an
assortment of information technology resources in information delivery oversight and
maintenance activities. There are a variety of relevant considerations regarding
information technology resources used to deliver information for precision medicine in
healthcare delivery organizations.
Big Data Analytics
Healthcare delivery organizations can use big data analytics to address a broad
range of issues. According to Kruse et al. (2016), there are several opportunities to apply
big data analytics in healthcare delivery such as to improve the quality of patient care,
increase operational efficiency, optimize decision making processes, and reduce costs.
Similarly, in a discussion of investing in big data analytics by healthcare stakeholder
organizations, Bates et al. (2018) explained that big data analytics are broadly applicable
to enhancing healthcare delivery using predictive methods to enhance patient care
quality, optimize operational processes, and improve resource utilization. Likewise,
according to Guha and Kumar (2018), big data analytics can be used to improve the
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quality of patient care, increase operational efficiency, and lower costs. Additionally, in a
systematic review of applications of big data analytics in the context of healthcare
management, Kamble et al. (2019) discussed that big data analytics provides insights,
enhances decision making, and improves service quality. Kamble et al. (2019) also
provided a particular example of how healthcare organizations can use big data analytics
in schedule planning. According to Kamble et al. (2019), big data analytics can be used to
predict if a patient will attend a future appointment based on past attendance records. Big
data analytics can be used to address a variety of issues associated with healthcare
delivery organizations.
In addition to the broad applicability in healthcare delivery organizations, big data
analytics are widely applicable to precision medicine in healthcare delivery. According to
Vegter (2018), big data analytics are inherent in precision medicine. Additionally,
Rumsfeld et al. (2016) explained that big data analytics are well suited for the size,
complexity, and integration of data used for precision medicine. Furthermore, in a
systematic review of applications of big data analytics in healthcare, Mehta and Pandit
(2018) discussed that big data analytics are clinically useful for precision medicine.
According to Mehta and Pandit (2018), big data analytics can be used to detect disease
early, accurately predict the path of disease, and select targeted treatment for precision
medicine. Big data analytics can be broadly applied to precision medicine in healthcare
delivery organizations.
Given the broad applicability of big data analytics, it is not surprising that
healthcare delivery organizations can use big data analytics to generate business value in
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several ways. In conceptual studies of how healthcare organizations can generate
business value using big data analytics, Wang and Hajli (2017) and Wang, Kung, Wang,
et al. (2018) concurred that the use of big data analytics in healthcare can lead to benefits
that are managerial, organizational, structural, strategic, and operational. Similarly, based
on a systematic review, Mehta and Pandit (2018) claimed that big data analytics can
provide value in healthcare by generating insights for operational benefit, clinical benefit,
and financial benefit. In different systematic review, Mikalef et al. (2018) argued that an
organization can generate business value using big data analytics to produce
transparency, enable experimentation, segment populations, improve decision making,
and innovate new services. Additionally, in a discussion of creating value using big data
analytics in healthcare, Lee and Yoon (2017) explained that big data analytics have
demonstrated value in clinical decision support and precision medicine. Furthermore, in a
systematic review of big data analytics in healthcare to identify types of organizational
and social value creation, Galetsi et al. (2019) explained that healthcare organizations can
obtain value by using big data analytics to provide personalized service, improve decision
making, innovate new services, manage performance, coordinate healthcare information,
create efficiency, avoid risks to patient care, customize services for population segments,
achieve cost effectiveness, and protect privacy. Healthcare delivery organizations can
create business value in several ways using big data analytics.
In regard to furthering the discussion of using big data analytics to create business
value, the creation of business value with big data analytics is affected by a mix of
organizational, human, and physical forms of information technology resources. In a
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case-based study of big data analytics and benefits for healthcare organizations, Wang,
Kung and Byrd (2018) argued that a blend of process, people, and information
technology provides the foundation to produce business value from information
technology. Additionally, in a study using Delphi and interview methods to examine
management challenges in generating business value from big data analytics, Vidgen et
al. (2017) suggested that a blend of organization, process, people, and technology affects
the creation of business value. A mix of different forms of information technology
resources affects the use of big data analytics to generate business value.
As well as affecting the creation of business value, a mix of organizational,
human, and physical forms of information technology resources can be used by
organizations to improve business performance with big data analytics. In a study
including survey and case study methods to investigate big data analytics resource
configurations that can generate business value, Mikalef et al. (2019) explained that big
data analytics can lead to high business performance based on a coalescence of
organization, process, people, technology, context, and data. In addition, Akter et al.
(2016) provided a study incorporating theoretical assumptions from sociomaterialism and
a resource-based view of the firm, which is the conceptual framework used in this study.
According to Akter et al. (2016), organizational performance has a statistically significant
positive relationship with a mixture of big data analytics management, big data analytics
talent, and big data analytics technology. Likewise, in a study using survey methods to
test a big data analytics model, Wamba et al. (2017) argued that organizational
performance has a statistically significant positive relationship with a blend of big data
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analytics management, big data analytics personnel, and big data analytics infrastructure.
Furthermore, in a study that included creating and using a survey instrument for the
assessment of big data analytics, Gupta and George (2016) explained that a combination
of organizational, human, and physical resources has a statistically significant positive
relationship with two different organizational performance measures. Organizations can
use big data analytics to increase business performance with a blend of physical, human,
and organizational forms of information technology resources.
To further the discussion of combining resources, a big data analytics capability is
a special type of resource that organizations can build by combining organizational,
human, and physical forms of information technology resources. According to Akter et
al. (2016), a big data analytics capability is built by integrating organizational, human,
and physical components. Similarly, Wamba et al. (2017) discussed that management,
personnel, and infrastructure components are combined to form a big data analytics
capability. Furthermore, Gupta and George (2016) argued that a combination of various
resources including a data-driven culture, managerial skills, investments, and technology
allow a company to create a big data analytics capability. As suggested in the literature,
organizations can create a big data analytics capability using a blend of organizational,
human, and physical forms of information technology resources.
A big data analytics capability includes organizational forms of resources in main
roles. According to Mikalef et al. (2018), the main intangible resources that permit a
company to develop a big data analytics capability are governance and data-driven
culture. Similarly, Gupta and George (2016) explained that the intangible resources of
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data-driven culture and intensity of organizational learning are statistically significant in
building a big data analytics capability. Additionally, Akter et al. (2016) and Wamba et
al. (2017) concurred that statistically significant management elements of a big data
analytics capability include investment, planning, control, and coordination.
Organizational forms of resources have key roles in a big data analytics capability.
Besides organizational forms of resources, human forms of resources have
significant roles in a big data analytics capability. According to Gupta and George
(2016), the human resources of managerial skills and technical skills are statistically
significant in building a big data analytics capability. Additionally, Akter et al. (2016)
and Wamba et al. (2017) concurred that statistically significant personnel elements of a
big data analytics capability include business knowledge, relational knowledge, technical
knowledge, and technology management knowledge. Similarly, Mikalef et al. (2018)
explained that the main knowledge resources that permit an organization to develop a big
data analytics capability are business knowledge, relational knowledge, technical
knowledge, and business analytics knowledge. Human forms of resources have main
roles in a big data analytics capability.
Like human and organizational forms of resources, physical forms of resources
have key roles in a big data analytics capability. According to Mikalef et al. (2018), the
main tangible resources needed to develop a big data analytics capability include data,
software, information systems, and infrastructure. Similarly, Gupta and George (2016)
explained that statistically significant tangible resources in building a big data analytics
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capability include data, technology, and basic resources such as time and investment.
Physical forms of resources have significant roles in a big data analytics capability.
In sum, a discussion of the literature about big data analytics provides several
relevant points to consider regarding this study. Healthcare delivery organizations can
broadly apply big data analytics for a range of issues including the provision of precision
medicine services. Healthcare delivery organizations can use big data analytics to
generate business value in several ways. The creation of business value with big data
analytics is affected by a mix of organizational, human, and physical forms of
information technology resources. A blend of different forms of information technology
resources can be used to improve business performance with big data analytics.
Organizations can build a special type of resource known as a big data analytics
capability by combining organizational, human, and physical forms of information
technology resources. There are several relevant considerations on the topic of big data
analytics regarding this study.
Genomic Testing
Genomic testing is widely applicable to precision medicine in healthcare delivery
organizations. According to Ronquillo et al. (2017), thousands of genomic tests for
precision medicine exist and have several purposes. Similarly, Khoury (2017) explained
that genomic tests for precision medicine are broadly available for disease prevention,
diagnosis, and treatment. Examples of genomic testing applications for precision
medicine include the prevention, diagnosis, and treatment of cancer and cardiovascular
disease (Krasi et al., 2019; Warner, Jain, et al., 2016), which are among the leading

52
causes of death globally (Cao et al., 2017). Additionally, reports indicate that healthcare
workers regularly use genomic test information in patient care decisions for precision
medicine (Dressler et al., 2018; Nadauld et al., 2018). Healthcare delivery organizations
can broadly apply genomic testing for precision medicine.
To further the discussion of genomic testing, reports of genomic testing regularly
include similar process steps. For instance, Aronson et al. (2016) discussed that the
genomic testing process at an academic medical center includes ordering a test,
performing the technical laboratory procedures, interpreting the technical results, and
delivering the results to healthcare workers. Similarly, Warner, Jain, et al. (2016)
explained that the process of genomic testing involves ordering a test, generating
technical lab results, interpreting technical lab results, and delivering results to healthcare
workers. Similar process steps for genomic testing are regularly discussed in reports.
Along with information about process, reports contain information regarding
information technology resources used in genomic testing. Reports of genomic testing
provide useful information about physical, human, and organizational forms of
information technology resources used for precision medicine. The following discussion
is based on information technology implementations for precision medicine in healthcare
delivery organizations.
Genomic testing process includes genomic test ordering procedures in which
healthcare delivery organizations use information technology resources for precision
medicine. For instance, according to Luzum et al. (2017), multiple healthcare systems use
electronic health record systems to order pharmacogenetic tests for precision medicine.
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Similarly, in the context of oncology, Levit et al. (2019) explained that healthcare
delivery organizations use electronic health record systems and clinical pathway systems
to order genomics tests for precision medicine. In a tutorial based on the experience of
two healthcare delivery organizations, Arwood et al. (2016) discussed that clinical
decision support can facilitate the ordering of genomic tests for precision medicine.
According to Arwood et al. (2016), clinical decision support can provide important
information to healthcare workers in the genomic test ordering process. In keeping with
the conceptual framework, electronic health record systems, clinical pathway systems,
and clinical decision support are examples of physical information technology resources.
Procedures to order genomic tests for precision medicine in healthcare delivery
organizations incorporate information technology resources.
As well as using information technology resources in procedures to order
genomic tests, healthcare delivery organizations use customized information technology
resources in genomic test laboratory procedures for precision medicine. For instance,
according to Manzi et al. (2017), a pediatric teaching hospital developed a customized
web-based software application to automatically translate raw genomic test output data
into a standard nomenclature. The ability to fulfill a need by creating and implementing
custom software is an example of an organizational capability, which is a type of
organizational information technology resource. In another case, Aronson et al. (2016)
explained that an academic medical center’s genetic testing laboratory uses multiple
customized information technology components. According to Aronson et al. (2016), the
customized information technology components include an enterprise gateway
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infrastructure system that can accommodate custom built laboratory information
management systems, a specialized system to support the use of synthetic nucleotides,
and a bioinformatic data pipeline to process raw genomic test output data. Genomic test
laboratory procedures for precision medicine in healthcare delivery organizations include
the use of customized information technology resources.
Healthcare delivery organizations not only use customized information
technology resources in genomic test laboratory procedures, but also incorporate
specialized information technology resources in procedures to interpret technical
genomic test results for precision medicine. For instance, in a discussion of genomic
testing practice models for precision medicine, Walko et al. (2016) explained that a
clinical cancer center developed a database with the assistance of a bioinformatics team
to bring together information from a variety of internal and external sources specifically
relevant to interpreting genomic test laboratory results for precision medicine. Walko et
al. (2016) also discussed that bioinformatics specialists serve on a committee responsible
for interpreting technical genomic test results for precision medicine. The use of
bioinformatics specialists provides an example of human information technology
resources. In a different case, Aronson et al. (2016) provided an account in which an
academic medical center performs tasks associated with the interpretation of technical
genomic test results using multiple special purpose information technology components.
According to Aronson et al. (2016), the special purpose information technology
components include a genomic knowledge base, a case repository, a spreadsheet template
which organizes relevant information, and customizable report templates. As another
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example, Manzi et al. (2017) explained that a pediatric teaching hospital uses a specially
designed software platform and carefully developed report templates containing dynamic
variables in procedures to interpret technical genomic test results for precision medicine.
Procedures to interpret technical genomic test results for precision medicine in healthcare
delivery organizations include the use of specialized information technology resources.
Besides using specialized information technology resources in procedures to
interpret technical genomic test results, healthcare delivery organizations incorporate
assorted information technology resources in procedures to deliver genomic test results
for precision medicine. For instance, in the context of pharmacogenomics, Caraballo,
Hodge, et al. (2017) explained that an academic medical center uses translation tables in
an electronic health record system to deliver standardized genomic test results that can
appear in modules as clinical problems, allergies, pop-up alerts, and inbox messages.
Caraballo, Hodge, et al. (2017) also explained that the academic medical center
coordinated among multiple laboratories to use standard definitions for the delivery of
genomic test results. In another case, Rosenman et al. (2017) provided an account in
which the main campus of a healthcare delivery organization delivers genomic test results
for precision medicine using email, fax, and an electronic health record system.
Rosenman et al. (2017) also explained that the test results can appear in modules of the
electronic health record system as full text reports, pop-up alerts, and clinical problems.
In a different account, according to Hicks, Stowe, et al. (2016), a multistate healthcare
delivery organization uses an electronic health record system to deliver genomic test
results in the form of lab results, pop-up alerts, and medication ordering considerations.
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Procedures to deliver genomic test results for precision medicine in healthcare delivery
organizations include the use of assorted information technology resources.
The use of information technology resources for precision medicine in healthcare
delivery organizations can be affected by the type of genomic test results. According to
Fujii et al. (2018), test results regarding the somatic genome can lose their relevance. For
instance, the TP53 and PIK3CA genes provide an example in which testing for somatic
genomic variation may need to be repeated when treating metastatic breast cancer
because the genes can mutate (Fujii et al., 2018). Whereas, according to Keeling et al.
(2019), test results regarding the inherited genome can be relevant throughout a person’s
lifetime for precision medicine. According to Hicks, Dunnenberger, et al. (2016), due to
the potential lifetime usefulness of test results regarding the inherited genome the test
results should be displayed independent of time. Additionally, Hinderer et al. (2017) and
Arwood et al. (2016) agreed that special consideration should be given to the storage of
genomic test results that have lifetime relevancy for patients. Furthermore, Caudle et al.
(2018) provided the view that genomic test results that are relevant over a person’s life
should be stored with standardized nomenclature to enable transfer to different electronic
health record systems. The type of genomic test results can affect the use of information
technology resources for precision medicine in healthcare delivery organizations.
In sum, a discussion of genomic testing provides several relevant points to
consider regarding this study. Genomic testing is widely applicable to precision medicine
in healthcare delivery organizations. Genomic testing processes commonly include test
ordering procedures, laboratory test procedures, technical test result interpretation

57
procedures, and test result delivery procedures. Healthcare delivery organizations use
physical, human, and organizational forms of information technology resources in
genomic testing for precision medicine. Healthcare delivery organizations use
customized, specialized, and assorted information technology resources in genomic
testing procedures. The type of genomic test results can affect the use of information
technology resources for precision medicine in healthcare delivery organizations. There
are several relevant considerations on the topic of genomic testing regarding this study.
Summary and Conclusions
As part of performing the literature review, I identified multiple frequently
occurring views that represent what is known regarding topics associated with this study.
The first view is that the field of precision medicine is emerging. Second, data analytics
is a vital component of precision medicine. Third, healthcare delivery organizations are in
early stages of applying precision medicine. Fourth, healthcare delivery organizations use
information technology to facilitate precision medicine. Fifth, healthcare delivery
organizations use specialized and customized information technology resources for
precision medicine. Sixth, healthcare delivery organizations use an assortment of
physical, human, and organizational forms of information technology resources for
precision medicine.
In addition to identifying themes in the literature I have found a lack of literature
about how researchers view certain qualities of information technology resources for
precision medicine in healthcare delivery organizations. I conducted this study in part
because the literature does not contain a consensus of information technology resource
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importance and feasibility for precision medicine in healthcare delivery organizations. A
detailed discussion of the research methods for this study is included in Chapter 3.
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Chapter 3: Research Method
The purpose of this classical Delphi study was to determine how a panel of
precision medicine information technology experts view information technology resource
importance and feasibility for precision medicine in healthcare delivery organizations. A
discussion of the research method, design, and procedures is included in Chapter 3. I
provide a rationale for selecting a qualitative method and a Delphi design. The role of the
researcher section includes a discussion of my participation in this study. In addition, I
explain the participant selection logic and the sampling strategy. The instrumentation
section contains a discussion about the questionnaire for each round. I also discuss
procedures for recruitment, participation, and data collection. I include information about
how I analyzed data in connection with the research questions. Furthermore, I discuss
issues of trustworthiness in terms of credibility, transferability, dependability, and
confirmability. I also describe procedures concerning ethical issues. The chapter
concludes with a summary of the important points.
Research Design and Rationale
Overarching research question: How does a panel of precision medicine
information technology experts view information technology resource importance and
feasibility for precision medicine in healthcare delivery organizations?
Subquestion 1: How does a panel of precision medicine information technology
experts view information technology resource importance for precision medicine in
healthcare delivery organizations?
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Subquestion 2: How does a panel of precision medicine information technology
experts view information technology resource feasibility for precision medicine in
healthcare delivery organizations?
As the research questions indicate, the main concept that I investigated in this
study is centered around information technology resources for precision medicine in
healthcare delivery organizations. There is a gap in knowledge regarding information
technology resource importance and feasibility for precision medicine in healthcare
delivery organizations. There are several unknowns regarding the future use of
information technology resources for precision medicine in healthcare delivery
organizations, and reporting consensus information from a Delphi study may aid people
in making information technology resource decisions.
I selected the qualitative research method for this study based on its being well
suited to address the research questions. According to Williams (2007), a researcher
selects the research method according to the type of data most appropriate for responding
to the research questions. Williams (2007) also mentioned that researchers can use a
qualitative method to understand details in situations that are complex. Similarly, Ravitch
and Carl (2016) explained that qualitative research is descriptive and fitting when
pursuing complexity. Additionally, Woods et al. (2016) discussed that qualitative
research combines knowledge and understanding to make judgements regarding the
circumstances. Addressing the research questions involved gathering assessment
information from knowledgeable people regarding a complex topic, which made a
qualitative method suitable for this study.
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When considering the literature, a Delphi design was appropriate for this study
given that addressing the research questions involved assessing importance and feasibility
information for a complex topic that is evolving and has many unknowns. According to
Rikkonen and Tapio (2009), a Delphi design is appropriate for topics in which changes in
trends are probable. Additionally, Delbecq et al. (1975) and Linstone and Turoff (2002)
concurred that a Delphi design is fitting when there is incomplete information regarding a
situation. Furthermore, Linstone and Turoff (2002) offered the view that a Delphi design
allows a group of people to jointly address a complex problem and is useful to assess
importance and feasibility of options. Linstone and Turoff (2002) also explained that the
need for a Delphi design can result from certain characteristics, including when exact
analytics are not suitable for working on a problem or when the participants needed to
examine a complex problem have not had prior communication. In addition, Delbecq et
al. (1975) discussed that a Delphi design can be useful for planning activities regarding
information technology. A Delphi design was well suited for this study in that addressing
the research questions involved assessing importance and feasibility information for a
complex topic that is evolving and has many unknowns.
I did not select a variety of research traditions because they were less suitable to
address the research questions when compared to a qualitative Delphi design. For
instance, according to Yilmaz (2013), a quantitative method is appropriate to measure
relationships between variables using preconstructed instruments into which participant
perspectives are expected to fit. Additionally, Yilmaz (2013) discussed that a quantitative
method is not fitting to capture the thoughts of participants in their own words.
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Furthermore, McCusker and Gunaydin (2015) explained that a quantitative method is
susceptible to excluding contextual detail. Additional examples of research traditions that
I did not select for this study include grounded theory, phenomenology, and ethnography.
According to Hays and Wood (2011), grounded theory is suitable when the goal is to
develop theory, phenomenology is fitting when the purpose is to describe the lived
experiences of participants, and ethnography is typically used when the goal is to identify
social patterns and norms. Another example of a research tradition that I did not select is
a mixed methods design. Leech and Onwuegbuzie (2009) provided the view that a mixed
methods design is mostly used for research questions that cannot be answered using a
single research tradition. I reviewed several research traditions that were less fitting to
address the research questions when compared to a qualitative Delphi design.
Role of the Researcher
Using the literature in support of conducting an ethically sound study by
incorporating procedures to minimize potential researcher bias was part of my role as a
researcher using a Delphi design. According to Avella (2016), in an effort to lessen
potential researcher bias, Delphi participant selection procedures should exclude
individuals with any type of personal or professional relationship with the researcher.
Additionally, Jenkins and Smith (1994) discussed that Delphi investigators can reduce the
potential for researcher bias by making an effort to preserve the wording of participants
found in collected text data. Furthermore, Kim and Yeo (2018) provided the view that
potential researcher bias can be reduced when using a Delphi method by specifying
procedures to assess if consensus has been reached among the participants. To minimize
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potential researcher bias, I incorporated the advice discussed into procedures associated
with participant selection and data analysis.
As a researcher using a Delphi design, my role included being an impartial
observer that interacted with participants. According to Avella (2016), a researcher using
a Delphi design should focus on recording and coordinating in an impartial manner rather
than contributing information. Additionally, Hirschhorn (2019) explained that the Delphi
process is directed by a coordinator that interacts with participants by distributing
questionnaires and results. Similarly, Raveenthiran and Sarin (2015) discussed that the
Delphi method involves a panel director facilitating responses from participants by
disseminating questionnaires, collecting responses, analyzing responses, and distributing
results. My role as a researcher using a Delphi design involved being an objective
observer that interacted with participants.
Methodology
Participant Selection Logic
The selection of participants is an important topic in a qualitative Delphi research
study. According to O'Reilly and Parker (2013), creating a saturated sample in qualitative
research involves selecting participants to create a collection of perspectives adequate to
provide the depth and breadth of data needed to address the research questions.
Additionally, Paré et al. (2013) explained that the selection of participants is critical for a
Delphi study, which is dependent on the knowledge of the panel members. Furthermore,
Goodman (1987) provided the view that if Delphi participants are knowledgeable about
the subject under investigation, then the study data are expected to be sound. In sum,
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conducting a sound qualitative Delphi research study depends on selecting
knowledgeable participants.
Sampling for this study incorporated the Delphi research practice of using
nonprobability purposive sampling supplemented with snowball sampling to identify
participants. According to Hasson et al. (2000), nonprobability purposive sampling is
often used by Delphi researchers to select experts for the purpose of applying knowledge
to a specific problem. Additionally, Skulmoski et al. (2007) explained that purposive
sampling can be supplemented with snowball sampling to identify additional participants
for Delphi studies. Furthermore, Habibi et al. (2014) discussed that nonprobability
snowball sampling is suitable when it may be difficult to locate potential participants. I
used nonprobability purposive and snowball sampling in this study.
I applied purposive and snowball sampling techniques in this study using multiple
participant selection criteria, which were mainly based on the literature. Delbecq et al.
(1975) explained that it is important for Delphi participants to have knowledge to
contribute and good writing ability. Similarly, according to Avella (2016), potential
Delphi participants should have expertise and the ability to write fluently. Likewise,
Skulmoski et al. (2007) discussed that Delphi participants are required to be
knowledgeable regarding the topic and able to communicate effectively. Additionally,
according to Avella (2016), Delphi researchers can avoid potential bias using the
relationship status between a potential participant and the researcher as a participant
selection criterion. Grisham (2009), de Manincor et al. (2015), and Skinner et al. (2016)
concurred that a minimum number of years of applicable professional experience can be
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used when selecting participants in a Delphi study. In this study, I included participants
from the population of individuals that met the participant selection criteria, which were
that an individual: (a) could describe cases illustrating good versus poor decisions
regarding information technology resources for precision medicine in healthcare delivery
organizations, (b) had a minimum of 3 years of professional experience dealing with
information technology for precision medicine in healthcare delivery, (c) could write
fluently in English, (d) did not have a personal or professional relationship with me, and
(e) was at least 18 years old. Applying the participant selection criteria produced a
homogenous sample in that participants had specialty knowledge within a given domain.
I sought a Delphi panel of at least 25 participants for this study. According to
Delbecq et al. (1975), sample sizes for Delphi studies vary and 10 – 15 participants may
be sufficient when the group is homogenous. Similarly, according to Hong et al. (2019),
sample sizes vary, and a sufficient homogenous Delphi sample is usually small, such as
10 – 15 participants. Furthermore, Donohoe and Needham (2009) explained that
participant attrition is a reality in Delphi studies and attrition rates of 50% have been
reported. Likewise, Briedenhann and Butts (2006) discussed that a Delphi sample size
should allow for attrition and cited an attrition rate of 48%. In sum, the desired sample
size for this study was at least 25 to guard against attrition.
Forming an adequate sample entailed following recruitment procedures. I used a
study invitation email to contact potential participants directly (see Appendix A). In
addition to describing the study, the message in the invitation included the opportunity to
suggest other individuals that might be interested in participating. Okoli and Pawlowski
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(2004) and Rowe and Wright (2011) agreed that recruiting for a Delphi study can include
snowball sampling. In the invitation, I also included a sentence explaining that a
monetary gift of up to 30 U.S. dollars would be provided. I performed targeted recruiting
using email addresses of authors that have written articles related to the research
questions. Briedenhann and Butts (2006) and Donohoe and Needham (2009) agreed that
potential participants for a Delphi can be identified using the literature. According to
Rowe and Wright (2011) and Okoli and Pawlowski (2004), the literature is a useful
source of information when forming a sample in a Delphi study. The literature contains
an assortment of authors that may have knowledge regarding the research questions. In
addition, I performed targeted searches on the internet to identify individuals believed to
possess knowledge related to the research questions. According to Goluchowicz and
Blind (2011), targeted internet searches can be used to identify panelists in a Delphi
study. Using an approach similar to Lin and Song (2015), I attempted to recruit people
having different work settings including academia and industry. I sent targeted study
invitations individually. I stopped sending invitations after an adequate sample was
formed. Given that the recruiting effort targeted people believed to have knowledge
related to the research questions, I asked volunteers that provided consent to complete the
eligibility questionnaire. I used responses to the eligibility questionnaire to determine if
volunteers met the participant selection criteria. For reference, Appendix B contains
screenshots of the eligibility questionnaire. Recruitment procedures provided a means to
form a sample.
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Instrumentation
Three questionnaires, one for each round, provided the data collection
instrumentation in accordance with the Delphi research tradition. Hsu and Sandford
(2007), Linstone and Turoff (2002), and Delbecq et al. (1975) agreed that a Delphi study
is conducted using a sequence of meticulously designed questionnaires to collect data in
which the responses collected from a questionnaire are used as input for the next
questionnaire. Delbecq et al. (1975) also explained that data collection stops once a
consensus is formed among the participants. Hasson et al. (2000) discussed that
determining the number of rounds is crucial given that too few can result in
nonmeaningful results and too many can cause participant fatigue. Powell (2003), Hsu
and Sandford (2007), and Custer et al. (1999) concurred that typically three rounds are
sufficient to reach consensus in a Delphi study. The instrumentation for data collection
consisted of three questionnaires, one for each round.
The Round 1 questionnaire contained open-ended questions (see Appendix C).
Hsu and Sandford (2007), Delbecq et al. (1975), and Powell (2003) agreed that typically
the Round 1 questionnaire contains open-ended questions that provide the basis for data
collection in that the collected responses will be incorporated into questionnaires that
follow. Powell (2003) also explained that open-ended questions prompt participants to
consider a topic broadly and allow for elaboration. According to Kalaian and Kasim
(2012), open-ended questions in the first round should be focused on the issue being
investigated. I used literature sources as the basis to determine the content of the Round 1
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questionnaire. After reviewing the literature, I constructed the Round 1 questionnaire
using open-ended questions that were focused on addressing the research questions.
I structured the Round 2 questionnaire so that participants could rate the
importance and feasibility of information technology resources identified in Round 1 as
well as optionally provide additional information technology resources (see Appendix D).
Powell (2003), Hsu and Sandford (2007), and Kalaian and Kasim (2012) concurred that
the Round 2 questionnaire commonly involves rating concepts derived from Round 1.
Kalaian and Kasim (2012) also explained that the Round 2 questionnaire often contains
structured closed-ended questions using a Likert-type scale. Sun et al. (2019), Linstone
and Turoff (2002), and Klenk and Hickey (2011) agreed that ordinal 5-point Likert-type
scales can be used to rate importance and feasibility in a Delphi study. I adopted the
scales for importance and feasibility from Gordijn et al. (2016) and Linstone and Turoff
(2002), respectively. Leyenaar et al. (2018), Custer et al. (1999), and Ludwig (1997)
concurred that a Delphi questionnaire structured to rate concepts can include a place for
participants to optionally suggest additional concepts. Considering that I could not
determine the content of the Round 2 questionnaire prior to conducting Round 1, it is
worth noting that the dependence of the Round 2 questionnaire content on the results of
Round 1 provides support for the validity of the content. The procedure to convert Round
1 responses to rating questions for the Round 2 questionnaire entailed analyzing the
responses using thematic analysis to condense the data. Condensing the data included
removing redundant information technology resources. I added the resulting set of unique
information technology resources to the Round 2 questionnaire in the form of importance
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and feasibility rating questions. In sum, the structure of the Round 2 questionnaire
allowed participants to optionally provide additional information technology resources as
well as rate the importance and feasibility of information technology resources derived
from Round 1 using ordinal 5-point Likert-type scales.
The structure of the Round 3 questionnaire allowed participants to rerate the
importance and feasibility of information technology resources from Round 2 that did not
have consensus of importance, feasibility, or both as well as rate the importance and
feasibility of additional information technology resources collected in Round 2 (see
Appendix E). Leyenaar et al. (2018), Ward et al. (2014), and Wester and Borders (2014)
agreed that the Round 3 questionnaire can be structured to rerate concepts from Round 2
that do not have consensus. Similar to the procedure used to convert Round 1 responses
to rating questions for the Round 2 questionnaire, the procedure to assess additional
information technology resources collected in Round 2 entailed performing thematic
analysis which included remove redundancies. New information technology resources
that were identified in Round 2 were added to the Round 3 questionnaire in the form of
importance and feasibility rating questions. The procedure to determine the rated
information technology resources from Round 2 that were to be included in the Round 3
questionnaire to be rerated entailed assessing if there was consensus of importance and
feasibility. I discuss the procedure that I used to decide if there was consensus in the data
analysis plan section below. When an information technology resource that was rated in
Round 2 did not have consensus of importance, feasibility, or both, the information
technology resource was added to the Round 3 questionnaire in the form of importance
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and feasibility rating questions. I structured the Round 3 questionnaire to allow
participants to rerate the importance and feasibility of information technology resources
from Round 2 that did not have consensus of importance, feasibility, or both as well as
rate the importance and feasibility of additional information technology resources that
were identified in Round 2.
Pilot and field tests of questionnaires are not typical in Delphi studies and were
not part of this study. According to Avella (2016), pilot studies and field tests are not
commonly used in Delphi studies. Additionally, Keeney et al. (2001) discussed that only
a few Delphi researchers conduct pilot tests. Furthermore, in a review of Delphi studies
about information systems, Paré et al. (2013) reported that less than one fifth of the
studies included instrument pretesting. Similarly, Clibbens et al. (2012) performed a
review of Delphi studies regarding healthcare of which less than one fourth included a
pilot study. Because pilot and field tests of questionnaires are not typical in Delphi
studies, I did not include the tests in this study.
Procedures for Recruitment, Participation, and Data Collection
As previously discussed, I performed targeted recruiting using email. I used the
literature and the internet to identify people believed to have knowledge related to the
research questions. In the invitation emails, I asked potential participants to email me if
they had an interest in participating. I emailed a consent form which included details
about the study to people that expressed an interest. The consent form explained that the
amount of the monetary gift was dependent on the level of participation. Completing each
of the Round 1, 2, and 3 questionnaires increased the amount of the gift 10 U.S. dollars
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for a possible total of $30. I asked individuals that wished to volunteer to provide consent
via email. I requested volunteers that provided consent to complete the eligibility
questionnaire. I provided access to the eligibility questionnaire using a Survey Monkey
website link. Clyne et al. (2012), Eleftheriadou et al. (2015), and Garofalo and Aggarwal
(2018) concurred that Survey Monkey can be used to administer questionnaires in a
Delphi study. I assessed responses to the eligibility questionnaire to determine if
volunteers met all the participant selection criteria. I sent an email to volunteers that did
not meet the participant selection criteria thanking them for volunteering and informing
them that they were not selected to participate in the study. I invited all respondents to the
eligibility questionnaire deemed eligible, according to the participant selection criteria, to
complete the Round 1 questionnaire. People that did not complete the Round 1
questionnaire in the allotted 2 week timeframe were excluded from future requests to
participate. Individuals that completed the Round 1 questionnaire made up the study
sample. I stopped recruiting after an adequate sample was formed.
Data collection entailed three rounds of questionnaires. The questionnaire for
each round should have taken approximately 15 minutes to complete. Okoli and
Pawlowski (2004), Soobiah et al. (2019), and Wilkes et al. (2016) concurred that 15
minutes to complete a questionnaire in a Delphi study is suitable. I scheduled 2 weeks for
each of the Round 1, 2, and 3 questionnaires to collect responses. Strear et al. (2018),
Toronto (2017), and Delbecq et al. (1975) agreed that a 2 week timeframe for participants
to complete a questionnaire is appropriate in a Delphi study. I used Survey Monkey
website links to provide participants access to the questionnaire for each round. In an
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attempt to enhance questionnaire response rates, reminder emails were sent to
nonresponding participants on day 7 and day 11 in each 2 week questionnaire timeframe.
Hasson et al. (2000) and Jenkins and Smith (1994) agreed that sending reminders is a
Delphi study technique used to improve response rates.
Part of the Delphi process is to provide participants controlled feedback between
the Round 1, 2, and 3 questionnaires. Hsu and Sandford (2007) and Meijering and Tobi
(2016) concurred that controlled feedback in a Delphi study consists of a summary of
results from the previous questionnaire. I provided controlled feedback to participants in
the form of summarized results. I emailed the Round 1 results to participants as an
attachment before distributing the website link for the Round 2 questionnaire. Similarly, I
emailed the Round 2 results to participants prior to distributing the website link for the
Round 3 questionnaire. I used Survey Monkey to generate the summary figures provided
in the Round 2 results.
When planning the overall schedule, I included a 2 week period after each of the
Round 1 and 2 questionnaires to allow for data analysis, sending feedback to participants,
creating the questionnaire for the next round, and review by Walden University
personnel. The use of a 2 week period between rounds is an approach that has been used
by other Delphi researchers (Strear et al., 2018). When considering the time between
questionnaires, I initially estimated the total data collection period to be 2.5 months. After
data collection was complete, I sent a conclusion email containing a summary of the
study results to the participants.
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Data Analysis Plan
I analyzed text data using thematic analysis. Powell (2003), Brady (2015), and de
Loë et al. (2016) concurred that thematic analysis is typically performed in a Delphi
study. I exported the text data from the Survey Monkey website into Microsoft Excel for
analysis. The use of Excel is common in previous Delphi studies (Briedenhann & Butts,
2006; O'Rourke et al., 2014). During the text data analysis, I made an effort to preserve
the wording used by participants as much as possible. Jenkins and Smith (1994)
discussed that preserving the words of Delphi participants is a tactic to minimize
potential researcher bias. I read the text data multiple times to become familiar with the
information technology resources in the data. According to Braun and Clarke (2006),
repeated reading of the data is a commonly used technique in the thematic analysis
process to immerse yourself in the data. After familiarization with the information
technology resources, I assigned at least one categorization code to each information
technology resource that I identified. Condensing the coded text data included removing
redundant information technology resources. The resulting set of information technology
resources is what participants rated in terms of importance and feasibility. I used
information technology resource importance and feasibility ratings to address research
subquestions 1 and 2. I performed thematic analysis on the text data collected to develop
a list of individual information technology resources that could be rated.
I analyzed information technology resource importance and feasibility ratings to
assess if there was consensus among the participants. I exported statistical information
for importance and feasibility ratings from Survey Monkey into Excel for analysis. Given
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that importance and feasibility ratings were both derived from ordinal 5-point Likert-type
scales, I used similar procedures to determine if there was consensus for each type of
rating. Consensus could have occurred at either end of a scale. Survey Monkey provided
the percent of responses received for each point on a scale. Using Excel, I summed the
percent of responses received for the first and second points of a scale in addition to
summing the percent of responses received for the fourth and fifth points of a scale. Fox
et al. (2016) and Sheinis and Selk (2018) agreed that summing responses at both ends of
a scale is appropriate in a Delphi study. I considered consensus to occur when a summed
value totaled at least 75%, which is a threshold commonly used in earlier Delphi studies,
according to Diamond et al. (2014). There were three possible results when analyzing
ratings data for an information technology resource. Depending on which type of rating,
if there was consensus at the beginning of a scale, I considered an information technology
resource either not important or not feasible. If there was consensus at the end of a scale,
I considered an information technology resource either important or feasible. I considered
importance or feasibility of an information technology resource to be undetermined if
there was not consensus. I analyzed information technology resource importance and
feasibility ratings to address research subquestions 1 and 2.
I analyzed demographic data collected using the eligibility questionnaire using
descriptive statistics to characterize the sample. After exporting responses to the
eligibility questionnaire from Survey Monkey, I generated statistical information for
demographic data using Excel. The use of descriptive statistics protects the identities of
participants. The analysis of demographic data that were nominal and ordinal entailed
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calculating frequency and percent values, similar to how Bobonich and Cooper (2012)
and Wiener et al. (2009) did. Like Nakatsu and Iacovou (2009) and Wilson et al. (2003), I
calculated the mean value for the years of professional experience. The analysis of the
demographic data entailed the use of descriptive statistics to characterize the sample.
Issues of Trustworthiness
Credibility
Credibility, sometimes referred to as internal validity, deals with the truthfulness
of the study results (Krefting, 1991; Morse, 2015). The literature contains several
techniques to help increase rigor and confidence in study findings. According to Shenton
(2004), confidence in the accuracy of qualitative research can be enhanced by adopting
research methods used in similar studies, using methods that encourage participants to be
frank, welcoming scrutiny of the research project by academic scholars, and reviewing
findings of similar studies. In this study, I included each tactic mentioned to improve
credibility. The research methods were mainly adopted from previous Delphi studies or
had been described by Delphi scholars. I kept participant identity confidential, which
encouraged participants to be frank. As part of the dissertation process, multiple Walden
University faculty members examined the research project and provided feedback. I
reviewed findings of similar studies during the literature review. I believe that the
techniques discussed have increased rigor and confidence in the truthfulness of the study
results.
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Transferability
Transferability, referred to as external validity in quantitative studies, is about the
applicability of the study findings in other contexts (Krefting, 1991; Thomas & Magilvy,
2011). Providing thick description of the study context enables readers to assess if the
study results are applicable in other contexts (Cope, 2013; Morse, 2015). Shenton (2004)
provided guidance on the information that researchers should provide to enable
transferability, which includes the number and type of participants, the data collection
methods, the number and duration of data collection events, and the duration of the data
collection phase. I followed the guidance mentioned to address the trustworthiness
criterion of transferability using thick description. I described the study context by
providing detailed information regarding the sample and data collection. The information
provided may aid readers in assessing if the findings of this study are transferable to other
contexts.
Dependability
Dependability, referred to as reliability on occasion, concerns the consistency of
the findings if the study were to be repeated (Morse, 2015; Shenton, 2004). The literature
contains an assortment of techniques that can be used to help ensure consistency in study
results. Krefting (1991) and Thomas and Magilvy (2011) concurred that providing thick
description of research methods is an appropriate strategy to help establish dependability.
In addition, Krefting (1991) discussed that having methodologists examine the research
plan is another way to enhance dependability. Furthermore, Morse (2015) and Thomas
and Magilvy (2011) agreed that the use of an audit trail is a suitable tactic to improve
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dependability. According to Thomas and Magilvy (2011), an audit trail includes a
description of the study purpose, a discussion of how the sample was formed, an
explanation of data collection methods and time frames, and a discussion of techniques
used to enhance credibility of the findings. In accord with the literature references, the
techniques I used to enhance dependability included providing thick description of
research methods, having methodologists examine the research plan, and using an audit
trail as discussed.
Confirmability
Conﬁrmability, sometimes referred to as objectivity, deals with the neutrality of
the results in that the findings should be based on the data collected from participants and
not affected by researcher bias (Krefting, 1991; Shenton, 2004). Engels and Kennedy
(2007) explained that the ability to trace findings back to original sources is a
requirement of confirmability. Anney (2014), Bowen (2009), and Tobin and Begley
(2004) concurred that an audit trail supports confirmability. In addition, according to
Cope (2013), providing participant quotes in connection with resulting themes is a valid
way to demonstrate that the results originate from the collected data. In this study, I
enhanced confirmability by using an audit trail and by including participant quotes in
connection with themes.
Ethical Procedures
The institutional review board at Walden University reviewed this study. Walden
University is the only organization involved with this study. I needed approval by the
institutional review board prior to conducting this study. The institutional review board
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approval number is 01-26-21-0646612. I believe the institutional review board has
considered several ethical aspects including factors associated with recruitment, informed
consent, data collection, and the treatment of data.
As previously discussed, targeted recruitment of study participants involved
emailing the study invitation directly to individuals believed to have knowledge related
the research questions. In the invitation, I asked potential participants to email me if they
had an interest in participating. I emailed a consent form that included details about the
study to people that expressed an interest. I asked individuals that wished to provide
informed consent to do so via email. I emailed volunteers that provided consent a Survey
Monkey website link to access the eligibility questionnaire. Similarly, I emailed website
links to participants to provide access to the questionnaire for each round. I believe that
communicating with each participant individually using email enhanced the ability to
keep participant identities confidential. I kept participant identities confidential including
in reports associated with this study.
I downloaded research data from the password protected Survey Monkey website
and stored the data on my password protected computer. I deleted data located on the
Survey Monkey website after the study ended. I will store the research data for a
minimum of 5 years on my personal computer. I may store the study data longer than 5
years for publication purposes. When it comes time to destroy the study data located on
my computer, I will delete the files.
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Summary
In sum, there were several important considerations regarding the methods used in
this study. A qualitative method and a Delphi design were appropriate to address the
research questions. I used multiple tactics to minimize potential researcher bias. I gave
the creation of a study sample careful consideration. I performed data collection using
three questionnaires, one for each round. In addition, I used data analysis results to
determine which information technology resources were considered important and
feasible. I also used several tactics to enhance the trustworthiness components of
credibility, transferability, dependability, and confirmability. Furthermore, I addressed
ethical aspects of the study. Having discussed the study methods in Chapter 3, Chapter 4
includes information regarding the study results.
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Chapter 4: Results
The purpose of this classical Delphi study was to determine how a panel of
precision medicine information technology experts view information technology resource
importance and feasibility for precision medicine in healthcare delivery organizations.
Determining a consensus of information technology resource importance and feasibility
may help address the problem of people having limited information when making
resource decisions for precision medicine in healthcare delivery organizations. This
Delphi study could provide information that aids people in making sound information
technology resource decisions for precision medicine in healthcare delivery
organizations. The research questions were as follows.
Overarching research question: How does a panel of precision medicine
information technology experts view information technology resource importance and
feasibility for precision medicine in healthcare delivery organizations?
Subquestion 1: How does a panel of precision medicine information technology
experts view information technology resource importance for precision medicine in
healthcare delivery organizations?
Subquestion 2: How does a panel of precision medicine information technology
experts view information technology resource feasibility for precision medicine in
healthcare delivery organizations?
This chapter includes information regarding the study results. The next section
contains a discussion of the research setting, which is followed by a section about
demographics of the study sample. I provide details regarding data collection and data
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analysis. I also discuss evidence of trustworthiness in terms of credibility, transferability,
dependability, and confirmability. In addition, I provide the study results. Chapter 4
concludes with a summary of the findings.
Research Setting
I conducted the study remotely using email to communicate with participants.
Little information is available about conditions participants were exposed to that may
have influenced the participants at the time of the study. One indicator of organizational
conditions is primary work setting, which I included as a demographic question. I limited
the possible responses to the primary work setting question to academia, industry, and
government. I provide the results of the primary work setting question in Table 1. Besides
primary work setting, no further information is available about conditions participants
were exposed to that may have influenced the participants at the time of the study.
Demographics
Recruitment results are summarized as follows. I distributed an estimated total of
15,000 study invitations via email during the period from 1/26/2021 to 3/30/2021. The
exact number is unknown because I received numerous email replies explaining that the
study invitation could not be delivered. I sent the consent form via email to 153 people
that replied to me after receiving the study invitation. A total of 90 people provided
consent. After a person provided consent, I emailed the person a link to the eligibility
questionnaire with a note explaining that the link was unique to the person. The note
indicated that responses would not be anonymous. Altogether, 79 people completed the
eligibility questionnaire. Even though the invitation and consent form clearly provided
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the eligibility requirements upfront, several people were ineligible based on their
responses to the eligibility questionnaire. According to responses to the eligibility
questionnaire, 63 people were eligible to participate. I invited all respondents to the
eligibility questionnaire deemed eligible, according to the participant selection criteria, to
complete the Round 1 questionnaire. The study sample only included people that
completed the Round 1 questionnaire. I sent an email to people that did not complete the
Round 1 questionnaire explaining that they would not be asked to participate in the study
going forward.
In addition to completing the Round 1 questionnaire, every member of the sample
met the participant selection criteria based on the responses to the eligibility
questionnaire. The participant selection criteria were that an individual: (a) could describe
cases illustrating good versus poor decisions regarding information technology resources
for precision medicine in healthcare delivery organizations, (b) had a minimum of 3 years
of professional experience dealing with information technology for precision medicine in
healthcare delivery, (c) could write fluently in English, (d) did not have a personal or
professional relationship with me, and (f) was at least 18 years old. The participant
selection criteria characterize the sample.
The sample is not only characterized by the participant selection criteria, but also
by statistical information. The average number of years of professional experience
dealing with information technology for precision medicine in healthcare delivery was
14.6 years for the study sample. As shown in Table 1, a high percentage of participants
reported working in an industry setting. Most participants reported having a doctorate
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degree (see Table 2). Participants primary job function varied (see Table 3). The four
participants that selected other for the primary job function, provided entries of: (a)
doctor, (b) physician informaticist - clinical informatics, (c) founder and chief executive
officer for clinical cloud, and (d) independent consultant. As shown in Table 4, the
majority of participants resided in the United States.

Table 1
Participants Primary Work Setting
Work setting

Participants
n

%

Industry

34

65

Academia

16

31

Government

2

4

Table 2
Participants Highest Degree Earned
Degree

Participants
n

%

Doctorate

34

65

Master’s

13

25

Bachelor’s

5

10

Associate’s

0

0

High school

0

0
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Table 3
Participants Primary Job Function
Job function

a

Participants
n

%a

Executive

19

37

Researcher

12

23

Director

9

17

Professor

4

8

Other

4

8

Manager

3

6

Engineer

1

2

Analyst

0

0

Percent values do not total 100 due to rounding.
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Table 4
Country in Which Participants Resided
Country

a

Participants
n

%a

United States

38

73

India

3

6

United Kingdom

2

4

Australia

1

2

Brazil

1

2

Canada

1

2

Netherlands

1

2

South Africa

1

2

South Korea

1

2

Spain

1

2

Sweden

1

2

Turkey

1

2

Percent values do not total 100 due to rounding.

Data Collection
Data collection occurred remotely by recording data using Survey Monkey.
Participants completed the questionnaire for each round online. I provide data collection
timeframes in Table 5. The timeframes for the Round 2 questionnaire and the Round 3
questionnaire correspond to the request for participants to complete each questionnaire
within 2 weeks. The timeframe for the Round 1 questionnaire was longer than 2 weeks
because I continued to perform recruitment activities concurrently with data collection
for Round 1. I distributed the Round 1 questionnaire during the period from 3/25/2021 to
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4/5/2021. I provide the number of participants that completed the questionnaire for each
round in Table 6.

Table 5
Data Collection Timeframes
Questionnaire

Start date

End date

Days
(n)

Round 1 questionnaire

3/25/2021

4/11/2021

18

Round 2 questionnaire

4/16/2021

4/29/2021

14

Round 3 questionnaire

5/8/2021

5/21/2021

14

Table 6
Questionnaire Completion Rates
Questionnaire

Questionnaires
distributed

Questionnaires
completed

Completion rate

Round 1 questionnaire

63

52

83%

Round 2 questionnaire

52

45

87%

Round 3 questionnaire

52

43

83%

I received a few emails from participants when conducting Round 2 that are noted
here. One person suggested that it may be beneficial to allow respondents to enter
comments for each item rated on the Round 2 questionnaire. Three other participants
suggested that they would prefer to rate a smaller list of items than what resulted from
Round 1. In sum, a few participants sent me comments during Round 2.
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Data Analysis
The process to perform thematic analysis on the text data collected during Round
1 involved familiarization and coding. After exporting the data from Survey Monkey into
Microsoft Excel, I read the responses multiple times to become familiar with the concepts
in the data. In a few cases, I used the Google search engine to find background
information about concepts that I knew little about. Additionally, I emailed two
participants in an attempt to clarify their responses. Once familiar with the concepts in
the Round 1 data, I began assigning category codes to the responses. I developed,
applied, and modified the codes in an iterative manner during the coding process. The
first pass entailed assigning at least one category code to each response. I proceeded by
sorting the data using the category codes to group the responses. I reviewed and adjusted
the category codes multiple times until the codes were applied consistently. I performed
familiarization and coding steps as part of the thematic analysis process.
After coding was complete, I condensed the Round 1 text data into themes. To
reduce the potential for researcher bias when forming themes, I made an effort to
preserve the wording used by participants as much as possible. When forming themes, I
noted and removed redundancies in the data. In cases where multiple responses conveyed
basically the same idea, I typically created the theme using the words from a descriptive
response. Additionally, I did not create themes for responses that did not appear to
address the research questions. For instance, I did not create themes for responses of x, y,
and same as answer #2. Tables 7 through 13 provide examples of the thematic analysis in
that the tables contain participant responses and category codes for specific themes that
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resulted during Round 1. I created themes by condensing the text data collected during
Round 1.
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Table 7
Reponses Used to Create the Theme Named: Advanced Clinical Decision Support
Capabilities
Participant
number

Response

Category codes

3

Clinical decision support

Decision support

4

Clinical decision support system

Decision support

5

Knowledge based system (clinical
decision support system)

Decision support and knowledge

6

Clinical decision support matrix

Decision support

19

Decision support tools for ordering

Decision support and ordering

28

CDST that enables evidence-based
guidance on multiple factors

Decision support and evidence
based

32

Decision support systems

Decision support

33

Advanced clinical decision support
capabilities

Decision support and advanced

36

Robust clinical decision support and
just-in-time point of care
educational resources to support
evidence based best practice

Decision support, robust, point of
care, educational, evidence based,
and best practice

40

CDS at clinic as well as pharmacy
levels

Decision support and pharmacy

45

Decision support systems

Decision support

45

Decision support systems linking
data with clinical decision making

Decision support

49

Point of care clinical decision
support

Decision support and point of care

51

Clinical decision support

Decision support

52

Clinical decision support built on
this data to help guide clinicians
with complex decisions

Decision support and complex

Note. CDS is an acronym for clinical decision support and CDST stands for clinical
decision support tool.
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Table 8
Reponses Used to Create the Theme Named: Artificial Intelligence Platforms
Participant
number

Response

Category codes

3

Artificial intelligence

Artificial intelligence

14

Artificial intelligence platforms

Artificial intelligence

16

Data analytics, artificial
intelligence, and machine learning

Artificial intelligence, analytics, and
machine learning

22

AI/ML

Artificial intelligence and machine
learning

25

IA a

Artificial intelligence

28

AI

Artificial intelligence

37

Artificial intelligence for discovery
& personalization of treatment

Artificial intelligence, discovery,
personalization, and treatment

39

AI

Artificial intelligence

39

AI

Artificial intelligence

47

Machine learning - artificial
intelligence

Artificial intelligence and machine
learning

Note. AI is an acronym for artificial intelligence and ML stands for machine learning.
a

The multilingual Spanish speaking participant intended to enter AI, which was clarified

via email.
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Table 9
Reponses Used to Create the Theme Named: Cloud Computing
Participant
number

Response

Category codes

2

Cloud services capable of hosting
Cloud, patient data, complex, and
patient data and running arbitrarily
machine learning
complex machine learning models
that can be easily updated

7

Cloud based data processing and
computing environment for model
building and deployment

Cloud, data processing, and model

10

Server for data processing or access
to cloud computing

Cloud, server, and data processing

16

Agnostic VNA/cloud technology

Cloud and vendor neutral archive

17

Cloud infrastructure

Cloud

20

Secure cloud platform for genomic
data

Cloud and genomic data

26

Cloud access

Cloud

31

Redshift DB

Cloud and data warehouse

44

Cloud computing

Cloud

48

Cloud / federated / distributed
solutions that store data (Amazon,
Storj/Sia,..)

Cloud, federated, and distributed

Note. VNA is an acronym for vendor neutral archive and DB stands for database.
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Table 10
Reponses Used to Create the Theme Named: Data Governance and Stewardship
Participant
number

Response

Category codes

3

Data stewardship

Data stewardship

5

Data governance

Data governance

27

Data management

Data management

27

Data governance

Data governance

29

Data governance / stewardship

Data governance and data
stewardship

38

Data management

Data management

42

Data management

Data management

Table 11
Reponses Used to Create the Theme Named: Data Scientists
Participant
number

Response

Category codes

12

Data scientist - creates and/or
manages analytics, visualizations

Data scientist, analytics, and
visualization

15

Data scientist

Data scientist

22

Data scientist

Data scientist

23

Data scientists

Data scientist

24

Data scientists

Data scientist

27

Not all places will do discovery, but
for those that do, trained data
scientists to find the correlations
needed for precision medicine

Data scientist, discovery, and find
correlations

29

Data scientist

Data scientist

37

Data scientists

Data scientist
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Table 12
Reponses Used to Create the Theme Named: Next Generation DNA Sequencing
Technology
Participant
number

Response

Category codes

7

Next generation sequencing (NGS)
DNA sequencing technology

Sequencing, next generation, and
DNA

10

Access to good sequencing
equipment to ensure quality

Sequencing and quality

14

Genome sequencing

Sequencing and genomic

22

Gene sequencer

Sequencing and genomic

43

NGS sequencing platforms

Sequencing and next generation

Note. NGS is an acronym for next generation sequencing and DNA stands for
deoxyribonucleic acid.

Table 13
Reponses Used to Create the Theme Named: Storage Solutions for Large Data Sets
Participant
number

Response

Category codes

5

Storage plan (server side)

Storage and server

10

Space for backup and data storage

Storage and backup

18

Storage solutions for large data sets

Storage and big data

29

Data storage for both pre and post analysis

Storage

40

Storage

Storage

Not only was thematic analysis performed in Round 1, but also in Round 2 since
the Round 2 questionnaire provided an opportunity to list additional information
technology resources. The thematic analysis process used in Round 2 was basically the
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same as the process used in Round 1. One additional step I performed in Round 2 was to
check that a theme had not already been identified in Round 1. Generally speaking,
additional themes were created by condensing the text data collected during Round 2.
I analyzed importance ratings collected during the second and third rounds to
determine if there was consensus among the participants. For each information
technology resource that was rated, Survey Monkey automatically calculated the percent
of responses received for each point on the 5-point importance scale. I exported the
percent information from Survey Monkey into Excel. I used Excel formulas to sum
percent values and determine if there was consensus. Consensus of importance could
have occurred in two different cases. The first case was when at least 75% of the ratings
fell in the rating categories of unimportant or very unimportant. If the first case was met,
I considered the information technology resource to be not important. The second case
was when at least 75% of the ratings fell in the rating categories of important or very
important. If the second case was met, I considered the information technology resource
to be important. When neither the first nor the second case occurred, I considered the
information technology resource to have undetermined importance.
Similar to the importance ratings, I analyzed feasibility ratings during Round 2
and Round 3 to determine if there was consensus among the participants. The analysis
process for feasibility ratings parallels the analysis process used for importance ratings.
After Survey Monkey autogenerated the percent of responses received for each point on
the 5-point feasibility scale, I exported the percent information into Excel. I used Excel
formulas to sum percent values and determine if there was consensus. Consensus of
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feasibility could have occurred in two different cases. The first case was when at least
75% of the ratings fell in the rating categories of probably infeasible or definitely
infeasible. If the first case was met, I considered the information technology resource to
be not feasible. The second case was when at least 75% of the ratings fell in the rating
categories of probably feasible or definitely feasible. If the second case was met, I
considered the information technology resource to be feasible. When neither the first nor
the second case occurred, I considered the information technology resource to have
undetermined feasibility.
Evidence of Trustworthiness
Credibility
Credibility, sometimes referred to as internal validity, deals with the truthfulness
of the study results (Krefting, 1991; Morse, 2015). According to Shenton (2004),
confidence in the accuracy of qualitative research can be enhanced by adopting research
methods used in similar studies, reviewing findings of similar studies, using methods that
encourage participants to be frank, and welcoming scrutiny of the research project by
academic scholars. In this study, I included each tactic mentioned to improve credibility.
The research methods were mainly adopted from previous Delphi studies or were
described by Delphi scholars. I reviewed findings of similar studies during the literature
review. To encourage participants to be frank, I kept participant identity confidential. As
part of the dissertation process, multiple Walden University faculty members examined
the research project and provided feedback. I used multiple techniques to increase rigor
and confidence in the truthfulness of the study results.
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Transferability
Transferability, referred to as external validity in quantitative studies, is about the
applicability of the study findings in other contexts (Krefting, 1991; Thomas & Magilvy,
2011). Providing thick description of the study context enables readers to assess if the
study results are applicable in other contexts (Cope, 2013; Morse, 2015). Shenton (2004)
provided guidance on the information researchers should provide to enable
transferability, which includes the number and type of participants, the data collection
methods, the number and duration of data collection events, and the duration of the data
collection phase. I followed the guidance mentioned to address the trustworthiness
criterion of transferability using thick description. I described the study context by
providing detailed information regarding the sample and data collection. The information
provided may aid readers in assessing if the findings of this study are transferable to other
contexts.
Dependability
Dependability, referred to as reliability on occasion, concerns the consistency of
the findings if the study were to be repeated (Morse, 2015; Shenton, 2004). Krefting
(1991) and Thomas and Magilvy (2011) concurred that providing thick description of
research methods is an appropriate strategy to help establish dependability. In addition,
Krefting (1991) discussed that having methodologists examine the research plan is
another way to enhance dependability. Furthermore, Morse (2015) and Thomas and
Magilvy (2011) agreed that the use of an audit trail is a suitable tactic to improve
dependability. According to Thomas and Magilvy (2011), an audit trail includes a
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description of the study purpose, a discussion of how the sample is formed, an
explanation of data collection methods and time frames, and a discussion of techniques
used to enhance credibility of the findings. In accord with the literature references, the
techniques I used to enhance dependability included providing thick description of
research methods, having methodologists examine the research plan, and using an audit
trail as discussed.
Confirmability
Conﬁrmability, sometimes referred to as objectivity, deals with the neutrality of
the results in that the findings should be based on the data collected from participants and
not affected by researcher bias (Krefting, 1991; Shenton, 2004). Engels and Kennedy
(2007) explained that the ability to trace findings back to original sources is a
requirement of confirmability. Anney (2014), Bowen (2009), and Tobin and Begley
(2004) concurred that an audit trail supports confirmability. In addition, according to
Cope (2013), providing participant quotes in connection with resulting themes is a valid
way to demonstrate that the results originate from the collected data. In this study, I
enhanced confirmability by using an audit trail and by including participant quotes in
connection with themes.
Study Results
Round 1
The Round 1 questionnaire generated 447 participant responses, which resulted in
a total of 114 information technology resources to be rated in Round 2. The full list of
114 information technology resources is available in Appendix F. In addition,
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information technology resources resulting from Round 1 are broken down in Table 14
according to the resource-based view of the firm, which served as the conceptual
framework. In a resource-based view, an organizational capability is a special subtype of
organizational resource (Makadok, 2001). The total number of organizational resources
in Table 14 includes 37 organizational capabilities.

Table 14
Round 1 Results Summary According to the Conceptual Framework
Resource type

No. of information
technology resources

Physical

49

Organizational

43

Human

22

Round 2
Of the 114 information technology resources that were rated in Round 2, the
predetermined consensus thresholds for importance and feasibility were met for 59. All
59 information technology resources were considered to be important and feasible. A list
of the important and feasible information technology resources is provided in Table 15
along with the resource type according to the conceptual framework. The entries in Table
15 are ordered by the percent agreement of being important and then by the percent
agreement of being feasible.
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Table 15
Information Technology Resources Deemed Important and Feasible During Round 2
Information technology resource

Resource
type a

%
agreement
of being
important b

%
agreement
of being
feasible c

Advanced clinical decision support capabilities

Organizational
[capability]

98

89

Data quality

Organizational
[capability]

98

84

Application programming interface (API)
management and integration

Organizational

93

87

Data governance and stewardship

Organizational

93

84

Ability to integrate external clinical decision
support with the EHR

Organizational
[capability]

93

78

Ontologies for data to make disparate data
accessible

Physical

93

78

Clinical informatics

Organizational
[capability]

91

96

Trained bioinformatics professionals

Human

91

93

Clinical informaticists

Human

91

91

Data scientists

Human

91

87

Data integration strategy

Organizational

91

80

Data security officer - ensures integrity of data
sources

Human

89

93

Application development, testing, deployment,
maintenance, and support

Organizational
[capability]

89

91

Big data analysis

Organizational
[capability]

89

91

Connectors for external data systems using
standards (e.g., HL7-FHIR)

Physical

89

89

Data science

Organizational
[capability]

89

89

Next generation DNA sequencing technology

Physical

89

89

Support for clinical terminology standards (e.g.,
ICD, SNOMED-CT, LOINC, and RxNorm)

Organizational
[capability]

89

89
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Information technology resource

Resource
type a

%
agreement
of being
important b

%
agreement
of being
feasible c

Clinical decision support knowledge

Human

89

84

Ability to deliver results in understandable and
tangible format to patients

Organizational
[capability]

89

82

Data modeling

Organizational
[capability]

89

82

A common data model for patient data that
enables rapid prototyping (e.g., OHDSI OMOP
CDM)

Physical

89

78

Well-annotated database for variant classification

Physical

89

76

Clinical staff knowledgeable in physician
workflow, pathology, and molecular testing

Human

87

89

Data architects

Human

87

89

Data visualization

Organizational
[capability]

87

89

Evidence based medicine clinical pathway tools

Physical

87

78

Integrated knowledge resources that support
informed decision making

Physical

84

91

Storage solutions for large data sets

Physical

84

91

Clinical informatics team composed of physician
informaticists, molecular medicine
subspecialists, and geneticists

Human

84

87

Curated data

Physical

84

84

Development, maturity, and uptake of standards
for data exchange (including sequencing,
genomics, proteomics, results, etc.)

Organizational
[capability]

84

84

Data security software - not just ransomware
protection but true data provenance and
protections against data tampering

Physical

84

82

Big data analytics framework for aggregating,
cleaning, and organizing data for meaningful
analysis

Organizational

84

80

Ability to capture and represent patient-entered
data and device output and integrate with
transactional medical data

Organizational
[capability]

84

76
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Information technology resource

Resource
type a

%
agreement
of being
important b

%
agreement
of being
feasible c

Ability to map over time as terminologies, such
as ICD, change

Organizational
[capability]

84

76

Data harmonization and normalization to ensure
data is accurately ingested and used

Organizational
[capability]

84

76

Access to educational content about precision
medicine for patients and providers

Physical

82

89

Genomic storage and processing system (i.e.,
genomics ancillary system)

Physical

82

89

Data engineer

Human

82

80

Expertise in machine learning

Human

82

80

Integration and extension of context in data
standards

Organizational
[capability]

82

80

Additional programming personnel to support
building advanced clinical decision support

Human

82

78

Software developer subject matter experts to
develop integrated tools that maximize the use
of data

Human

82

78

Fast Healthcare Interoperability Resources
(FHIR) expertise

Human

80

91

Bioinformatics

Organizational
[capability]

80

89

Data engineering

Organizational
[capability]

80

80

Remote patient monitoring technology

Physical

80

80

Ability to represent key precision medicine data
elements (e.g., gene names, genomic variants,
and phenotypes) as structured data in the EHR

Organizational
[capability]

80

78

Systems integration specialist

Human

78

84

Biomedical information retrieval (IR) systems

Physical

78

82

Translational informatics

Organizational
[capability]

78

82

CMIO, CHIO, or CCIO - to enable clinical
application of new knowledge from analytics

Human

78

80
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Information technology resource

Resource
type a

%
agreement
of being
important b

%
agreement
of being
feasible c

Additional processing capacity for huge
databases holding precision medicine data

Physical

78

78

Digital front door framework - strong digital
connectivity with patients when not in a facility
or clinic

Organizational

78

78

High performance computing (HPC)
environment, such as graphics processing unit
(GPU) clusters or supercomputers, to process
protected health information

Physical

78

78

Analytic dashboards

Physical

76

93

Statistical thinking

Human

76

80

Virtual patient portal for information exchange
and real time documentation

Physical

76

76

Note. An information technology resource was considered important when at least 75%
of the ratings fell in the rating categories of important or very important. An information
technology resource was considered feasible when at least 75% of the ratings fell in the
rating categories of probably feasible or definitely feasible. The acronyms include: (a)
CCIO, chief clinical informatics officer; (b) CDM, common data model; (c) CHIO, chief
health information officer; (d) CMIO, chief medical information officer; (e) DNA,
deoxyribonucleic acid; (f) EHR, electronic health record; (g) FHIR, Fast Healthcare
Interoperability Resources; (h) HL7, Health Level Seven; (i) ICD, International
Classification of Diseases; (j) LOINC, Logical Observation Identifiers Names and Codes;
(k) OHDSI, Observational Health Data Sciences and Informatics; (l) OMOP,
Observational Medical Outcomes Partnership; and (m) SNOMED-CT, Systemized
Nomenclature of Medicine - Clinical Terms.
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a

The resource type for an organizational resource that has a resource subtype of

organizational capability is denoted as organizational [capability]. b The percent of
responses in the important or very important rating categories. c The percent of responses
in the probably feasible or definitely feasible rating categories.

Considering that only 59 out of the 114 information technology resources rated in
Round 2 met the predetermined consensus thresholds for importance and feasibility,
further assessment was needed for the 55 information technology resources that were
considered to have undetermined importance, undetermined feasibility, or both. I
provided summary information about importance and feasibility ratings for the 55
information technology resources to participants prior to Round 3 (see Appendix G). The
summary information allowed participants to consider the group’s position relative to
their own. In Round 3, I asked participants to rerate the 55 information technology
resources in an attempt to determine importance and feasibility.
The raw data collected in Round 2 included a total of 80 free text responses,
which resulted in identifying 45 additional information technology resources using
thematic analysis. A list of the 45 additional information technology resources can be
found at the end of Appendix G. I added the additional information technology resources
to the Round 3 questionnaire to be rated in terms of importance and feasibility. Table 16
provides a summary of the 45 additional information technology resources identified
during Round 2 according to the conceptual framework. The resource subtype known as
an organizational capability accounts for 14 of the organizational resources in Table 16.
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Table 16
Summary of Additional Information Technology Resources Identified During Round 2
Resource type

No. of additional information
technology resources

Organizational

17

Human

15

Physical

13

Round 3
Of the 100 information technology resources that participants rated in Round 3,
the predetermined consensus thresholds for importance and feasibility were met for 18.
All 18 information technology resources were considered important and feasible. A list of
the 18 information technology resources is provided in Table 17 along with the resource
type according to the conceptual framework. I grouped the entries in Table 17 by the
round that the information technology resource originated in. Within the groups, I
ordered the table entries by the percent agreement of being important and then by the
percent agreement of being feasible.
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Table 17
Information Technology Resources Deemed Important and Feasible During Round 3
Information technology resource

Resource
type a

%
agreement
of being
important b

%
agreement
of being
feasible c

Integration of EHR, genomic, and
pharmacologic platforms

Organizational
[capability]

91

79

Natural language processing

Physical

88

77

Application programming interface (API)
with labs that offer genetic or precision
testing

Physical

81

77

Clinical decision support customizability

Physical

81

77

Computational biology

Organizational
[capability]

79

84

Cloud computing

Physical

77

93

Ability to capture genetic variants and their
meaning in genomic sequence

Organizational
[capability]

77

77

Collaborative teams that include experienced
physicians working with engineers and
data scientists

Human

95

86

The necessary subject matter experts across a
variety of disciplines (e.g., integration,
genomics, data science, data architecture,
etc.)

Human

86

86

Clinical decision support architect

Human

84

91

Fast Healthcare Interoperability Resources
(FHIR)

Physical

84

88

Someone that has knowledge of both clinical
informatics and bioinformatics

Human

84

86

Someone with expertise to create precision
clinical decision support

Human

84

84

Fast Healthcare Interoperability Resources
(FHIR) clinical decision support tool

Physical

84

81

Originated during Round 1

Originated during Round 2
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Information technology resource

Resource
type a

%
agreement
of being
important b

%
agreement
of being
feasible c

Application programming interface (API)
development by EHR vendors

Organizational
[capability]

84

79

Predictive analysis

Organizational
[capability]

81

77

Data standardization experts

Human

79

81

Scientific publication access

Physical

77

79

Note. An information technology resource was considered important when at least 75%
of the ratings fell in the rating categories of important or very important. An information
technology resource was considered feasible when at least 75% of the ratings fell in the
rating categories of probably feasible or definitely feasible. EHR is an acronym for
electronic health record.
a

The resource type for an organizational resource that has a resource subtype of

organizational capability is denoted as organizational [capability]. b The percent of
responses in the important or very important rating categories. c The percent of responses
in the probably feasible or definitely feasible rating categories.

Considering that only 18 out of the 100 information technology resources rated in
Round 3 met the predetermined consensus thresholds for importance and feasibility, the
other 82 information technology resources were considered to have undetermined
importance, undetermined feasibility, or both. I list the 82 information technology
resources in Table 18 along with the resource type according to the conceptual
framework.
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Table 18
Information Technology Resources Considered to Have Undetermined Importance, Undetermined Feasibility, or Both
Information technology resource

Resource
type a

Importance b

Feasibility c

%
agreement
of being
not
important d

%
agreement
of being
important e

%
agreement
of being
not
feasible f

%
agreement
of being
feasible g

Originated during Round 1
Ability to capture granular phenotypes using EHR data
(i.e., deep phenotyping)

Organizational
[capability]

5

88

16

58

Access to electronic medical records and clinical genomics
research data

Physical

0

86

5

72

Ability to enable pragmatic clinical trials that seamlessly
integrate with the standard course of care

Organizational
[capability]

2

86

9

60

Ability to evaluate the effectiveness of artificial intelligence
and machine learning models that use genomic, social
determinant, and EHR data

Organizational
[capability]

2

86

14

58

Platform integration across devices

Organizational
[capability]

2

81

2

74

Ability to record and catalogue raw unstructured patient
data (e.g., notes, images, etc.)

Organizational
[capability]

9

81

12

65

IT infrastructure to capture real time events (e.g.,
emergency department admissions related to adverse drug
events)

Physical

5

81

7

65
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Information technology resource

Resource
type a

Importance b

Feasibility c

%
agreement
of being
not
important d

%
agreement
of being
important e

%
agreement
of being
not
feasible f

%
agreement
of being
feasible g

Ability to rapidly adopt new and evolving standards (e.g.,
FHIR and genomic implementation guides)

Organizational
[capability]

5

81

7

60

Data capture for patients in different populations to avoid
bias based on location, sex, social determinants of health,
or chronic conditions

Organizational
[capability]

2

81

9

60

Big data platform - large scale analytics support
incorporating whole-view data for a patient (e.g., clinical,
biometric, sequencing, population health, etc.)

Physical

0

79

12

53

Ability to execute and maintain artificial intelligence and
machine learning models and integrate them into
clinicians' workflows seamlessly

Organizational
[capability]

2

79

9

44

Enhanced ability to capture and use patient provided
information to incorporate patient preferences into
treatment plan and capture patient reported outcomes

Organizational
[capability]

0

77

2

67

Analysis provenance and traceability of results

Organizational
[capability]

2

77

2

60

Automated event detection and reporting systems for drug
reaction, medication dispensing, etc.

Physical

0

77

7

60

Ability to develop artificial intelligence and machine
learning models using genomic, social determinant, and
EHR data

Organizational
[capability]

9

77

9

49
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Information technology resource

Resource
type a

Importance b

Feasibility c

%
agreement
of being
not
important d

%
agreement
of being
important e

%
agreement
of being
not
feasible f

%
agreement
of being
feasible g

Adaptable and expandable data architecture

Physical

2

72

2

74

Clinical bioinformatics in which clinical and bioinformatic
aspects can be used with artificial intelligence and
machine learning

Organizational
[capability]

2

72

0

74

An integrated data environment that can support medical
care, financial transactions, quality improvement, and
research

Physical

7

72

12

53

Access to a global database and a database that is relevant
to the local population

Physical

0

72

19

40

Clinical trials infrastructure built in

Physical

0

70

2

67

Multimodal clinical data repository

Physical

0

70

2

67

IT infrastructure connected to a data warehouse for health
services research and economic estimates for the impact
of personalized medicine (e.g., emergency department
admissions and expenses related to adverse drug events
before and after the introduction of a pharmacogenetic
program to screen all adults for FDA related drug-gene
interactions)

Physical

2

70

7

60

Artificial intelligence platforms

Physical

0

67

0

72
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Information technology resource

Resource
type a

Importance b

Feasibility c

%
agreement
of being
not
important d

%
agreement
of being
important e

%
agreement
of being
not
feasible f

%
agreement
of being
feasible g

Native interoperability and application programming
interface (API) connectivity between EHR, electronic
case report form (eCRF), and biobank databases

Physical

2

67

2

65

Artificial intelligence in solving protein structures and
understanding their role in different pathway mechanisms

Physical

2

67

5

44

Terminologists

Human

5

65

5

70

Data lakes that can be federated

Physical

7

65

0

63

Artificial intelligence in next generation sequencing
technologies

Physical

2

65

5

58

Agile management

Organizational

2

60

0

70

Federated data analytics

Organizational
[capability]

5

60

7

63

Knowledge graphs

Physical

2

60

0

63

Artificial intelligence and machine learning to detect the
severity of diseases using computed tomography (CT)
images

Physical

9

58

7

65

Mobile device data and metadata

Physical

7

58

5

63

Artificial intelligence in drug discovery using simple
molecular docking and virtual screening approaches

Physical

5

58

7

53

Cloud services specialist

Human

9

56

2

88

111
Information technology resource

Resource
type a

Importance b

Feasibility c

%
agreement
of being
not
important d

%
agreement
of being
important e

%
agreement
of being
not
feasible f

%
agreement
of being
feasible g

Temporal reasoning

Human

7

56

9

51

Semantic modeling

Organizational
[capability]

7

56

2

42

Agnostic cloud technology and a vendor neutral archive

Physical

14

53

5

49

Edge computing that allows local processing of medical
data (e.g., smart watch)

Physical

9

51

0

72

Computer vision

Physical

5

49

0

67

Chatbots or other tools that streamline patient outreach by
not requiring a clinician

Physical

19

49

5

60

Artificial intelligence chips (also called artificial
intelligence hardware or artificial intelligence
accelerators)

Physical

16

47

9

42

Pathway software to enable the understanding of
mechanisms (e.g., Elsevier Pathway Studio)

Physical

16

44

0

60

Conversational artificial intelligence

Physical

12

44

5

51

Expertise in conversational artificial intelligence

Human

21

37

5

49

Drools and CQL developers

Human

14

35

0

53

Blockchain technology

Physical

28

30

5

53

Blockchain specialist

Human

33

30

7

51
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Information technology resource

Resource
type a

Importance b

Feasibility c

%
agreement
of being
not
important d

%
agreement
of being
important e

%
agreement
of being
not
feasible f

%
agreement
of being
feasible g

Originated during Round 2
Interoperability across different platforms (e.g., EHR,
genomic data, etc.)

Organizational
[capability]

0

98

7

72

Knowledge management with clinical and IT personnel

Organizational
[capability]

5

86

2

74

Interoperability experts

Human

0

84

0

70

Fast Healthcare Interoperability Resources (FHIR)
genomics standards for discrete results, data alignment,
and storage

Physical

2

84

0

65

Knowledge about EHR integration options that minimize
alert fatigue and provide precision recommendations

Human

2

79

7

72

Preparation for clinical decision support that scales to
thousands of rules

Organizational

2

79

0

70

Genomics laboratory information system that stores
sequencing data and can translate results into an
understandable narrative for the provider

Physical

2

79

5

65

Preparation for precision medication that leverages
molecular (e.g., DNA) findings

Organizational

0

77

5

74

More sustainable genomic nomenclature (e.g., Human
Genome Variation Society nomenclature)

Physical

5

77

0

70
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Information technology resource

Resource
type a

Importance b

Feasibility c

%
agreement
of being
not
important d

%
agreement
of being
important e

%
agreement
of being
not
feasible f

%
agreement
of being
feasible g

Software engineering

Organizational
[capability]

2

74

0

84

Substitutable Medical Apps and Reusable Technology
(SMART) on Fast Healthcare Interoperability Resources
(FHIR)

Physical

2

74

0

77

Pilot testing capabilities

Organizational
[capability]

5

74

5

72

Genomic nomenclature converting tools across multiple IT
platforms

Physical

5

74

0

58

Pilot testing environment

Physical

5

72

5

81

Program manager for precision medicine initiative
execution

Human

2

72

2

79

Machine learning capability

Organizational
[capability]

5

72

0

72

Real world data literacy

Human

2

72

12

51

Use case design

Organizational
[capability]

2

70

2

77

Patient data and educational resources outside the EHR

Physical

7

67

12

67

Transnational knowledge base (e.g., CPIC guideline)

Physical

7

65

0

63
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Information technology resource

Resource
type a

Importance b

Feasibility c

%
agreement
of being
not
important d

%
agreement
of being
important e

%
agreement
of being
not
feasible f

%
agreement
of being
feasible g

Human factor engineering - taking clinician and patient
personas into account

Organizational
[capability]

5

65

5

53

Knowledge about deep learning

Human

9

63

2

72

Translational knowledge engineering

Organizational
[capability]

7

63

5

56

Task force to implement new technologies

Human

2

60

2

67

Open source commercial software

Physical

19

60

14

49

Increased number of full-time equivalents (FTEs)

Human

5

60

14

47

Contract specialist among providers, researchers, vendors,
and the government

Human

12

56

5

58

Computer vision expertise

Human

5

47

2

63

3D printing

Organizational
[capability]

28

40

0

79

Supercomputer management

Organizational

19

37

7

56

Healthcare virtual and augmented reality

Organizational
[capability]

28

37

5

47

Nanotechnology

Organizational
[capability]

26

33

7

42

Development of quantum computing solutions

Organizational
[capability]

23

30

9

35
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Information technology resource

No code and low code machine learning solutions

Resource
type a

Physical

Importance b

Feasibility c

%
agreement
of being
not
important d

%
agreement
of being
important e

%
agreement
of being
not
feasible f

%
agreement
of being
feasible g

19

28

9

30

Note. An information technology resource was considered to have undetermined importance when at least 75% of the ratings did
not fall in the rating categories of unimportant or very unimportant and at least 75% of the ratings did not fall in the rating
categories of important or very important. An information technology resource was considered to have undetermined feasibility
when at least 75% of the ratings did not fall in the rating categories of probably infeasible or definitely infeasible and at least 75%
of the ratings did not fall in the rating categories of probably feasible or definitely feasible. The acronyms include (a) CPIC,
Clinical Pharmacogenetics Implementation Consortium; (b) CQL, Clinical Quality Language; (c) DNA, deoxyribonucleic acid;
(d) EHR, electronic health record; (e) FDA, Food and Drug Administration; (f) FHIR, Fast Healthcare Interoperability Resources;
and (g) IT, information technology.
a

The resource type for an organizational resource that has a resource subtype of organizational capability is denoted as

organizational [capability]. b Adding the percent agreement of being not important to the percent agreement of being important
and then subtracting the sum from 100 will approximate the percent of responses in the rating category of neutral. c Adding the
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percent agreement of being not feasible to the percent agreement of being feasible and then subtracting the sum from 100 will
approximate the percent of responses in the rating category of may or may not be feasible. d The percent of responses in the
unimportant or very unimportant rating categories. e The percent of responses in the important or very important rating categories.
f

The percent of responses in the probably infeasible or definitely infeasible rating categories. g The percent of responses in the

probably feasible or definitely feasible rating categories.
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Summary
A total of 159 information technology resources were identified and rated in terms
of importance and feasibility. The predetermined consensus thresholds for importance
and feasibility were met for 77 information technology resources. All 77 information
technology resources that met the predetermined consensus thresholds were considered
important and feasible. Table 19 summarizes the 77 information technology resources
considered important and feasible according to the conceptual framework, which was the
resource-based view of the firm. I considered the other 82 information technology
resources to have undetermined importance, undetermined feasibility, or both. I provide
a summary of the information technology resources that did not reach the predetermined
consensus threshold for importance, feasibility, or both in Table 20.
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Table 19
Summary of Information Technology Resources Deemed Important and Feasible
Resource type

No. of information
technology resources

Organizational

30 a

Physical

25

Human

22

Note. An information technology resource was considered to be important when at least
75% of the ratings fell in the rating categories of important or very important. An
information technology resource was considered to be feasible when at least 75% of the
ratings fell in the rating categories of probably feasible or definitely feasible.
a

The resource subtype of organizational capability accounts for 25 of the organizational

resources.
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Table 20
Summary of Information Technology Resources Considered to Have Undetermined
Importance, Undetermined Feasibility, or Both
Resource type

No. of information
technology resources
considered important
and having
undetermined
feasibility

No. of information
technology resources
considered feasible
and having
undetermined
importance

No. of information
technology resources
having undetermined
importance and
undetermined
feasibility

Organizational

15 a

3b

12 c

Physical

7

2

28

Human

2

2

11

Note. An information technology resource was considered important when at least 75%
of the ratings fell in the rating categories of important or very important. An information
technology resource was considered feasible when at least 75% of the ratings fell in the
rating categories of probably feasible or definitely feasible. An information technology
resource was considered to have undetermined importance when at least 75% of the
ratings did not fall in the rating categories of unimportant or very unimportant and at least
75% of the ratings did not fall in the rating categories of important or very important. An
information technology resource was considered to have undetermined feasibility when at
least 75% of the ratings did not fall in the rating categories of probably infeasible or
definitely infeasible and at least 75% of the ratings did not fall in the rating categories of
probably feasible or definitely feasible.
a

The resource subtype of organizational capability accounts for 13 of the organizational

resources. b The resource subtype of organizational capability accounts for 3 of the
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organizational resources. c The resource subtype of organizational capability accounts for
10 of the organizational resources.

Having presented the study results, the next chapter concludes the study. Chapter
5 includes an interpretation of the findings and limitations. In addition, the last chapter
includes recommendations for additional research, study implications, and a conclusion
section.
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Chapter 5: Discussion, Conclusions, and Recommendations
The purpose of this classical Delphi study was to determine how a panel of
precision medicine information technology experts view information technology resource
importance and feasibility for precision medicine in healthcare delivery organizations.
When considering the literature, a Delphi design was appropriate for this study given that
addressing the research questions involved assessing importance and feasibility
information for a complex topic that is evolving and has many unknowns. According to
Rikkonen and Tapio (2009), a Delphi design is appropriate for topics in which changes in
trends are probable. In addition, Delbecq et al. (1975) and Linstone and Turoff (2002)
concurred that a Delphi design is fitting when there is incomplete information regarding a
situation. In accord with Linstone and Turoff (2002), the Delphi design allowed a group
of people to jointly address a complex problem and assess importance and feasibility of
options.
An important reason I conducted this study is that people have incomplete
information to use when making decisions regarding information technology resources
for precision medicine in healthcare delivery organizations. The study results may
provide information to aid people in making well-informed information technology
resource decisions for precision medicine in healthcare delivery organizations. Of the 159
information technology resources rated by participants, the predetermined consensus
thresholds for importance and feasibility were met for 77 information technology
resources. All 77 information technology resources were considered important and
feasible. I considered the other 82 information technology resources to have
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undetermined importance, undetermined feasibility, or both. The next section of this
chapter includes an interpretation of the findings. Then I discuss study limitations,
recommendations for further research, and implications regarding practice, theory, and
positive social change. The last section of the chapter concludes the study.
Interpretation of Findings
To my knowledge, this is the first study conducted to determine how a panel of
precision medicine information technology specialists view information technology
resource importance and feasibility for precision medicine in healthcare delivery
organizations. The study results extend the information found in the literature in that the
results contain a consensus of information technology resources considered important and
feasible for precision medicine in healthcare delivery organizations. The results unite
several separate discussions in the literature to form a more comprehensive view on the
subject that I investigated.
Information technology resources regarding data science that were deemed
important and feasible for precision medicine in healthcare delivery organizations are in
line with writings about data science in the context of precision medicine. For instance,
the literature contains claims that precision medicine is deeply connected to data science
and that big data science provides an epistemological base for precision medicine
(Fröhlich et al., 2018; Vegter, 2018). Although the study results do not definitively prove
the claims made in the literature regarding data science, the findings provide support for
the claims. The information technology resources deemed important and feasible for
precision medicine in healthcare delivery organizations not only include data science,
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which I categorized as an organizational capability according to the conceptual
framework, but also include data scientists, who are human information technology
resources. Five additional information technology resources deemed important and
feasible include expertise in machine learning, statistical thinking, data visualization,
predictive analysis, and natural language processing. The concepts embedded in the five
additional information technology resources are often associated with data science
(Misnevs & Jackiva, 2016; Raschka et al., 2020). Information technology resources
regarding data science that were deemed important and feasible are in line with writings
about data science.
Given the link between precision medicine and data science, it comes as no
surprise that information technology resources considered important and feasible for
precision medicine in healthcare delivery organizations that incorporate big data are in
accord with literature references. As an example, Wu et al. (2017) and Gligorijević et al.
(2016) agreed that big data analytics enable precision medicine. In accord with Wu et al.
(2017) and Gligorijević et al. (2016), information technology resources considered
important and feasible for precision medicine in healthcare delivery organizations include
big data analysis, which I categorized as an organizational resource, and a big data
analytics framework for aggregating, cleaning, and organizing data for meaningful
analysis, which I categorized as an organizational capability. As another example,
Moscatelli et al. (2018) discussed an optimized way to store big data for precision
medicine. In accord with Moscatelli et al. (2018), storage solutions for large data sets
were considered a physical information technology resource that is important and feasible
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for precision medicine in healthcare delivery organizations. Information technology
resources considered important and feasible that incorporate big data are in accord with
literature references.
With the connections of precision medicine to big data and data science, it makes
sense that information technology resources deemed important and feasible for precision
medicine in healthcare delivery organizations that are related to data standards are
congruent with discussions in the literature. For instance, in a discussion of using
electronic health record systems for precision medicine, Sitapati et al. (2017) explained
that terminology standards enable healthcare organizations to exchange health data.
Congruent with the discussion by Sitapati et al. (2017), support for clinical terminology
standards was deemed an important and feasible information technology resource for
precision medicine in healthcare delivery organizations. In keeping with the conceptual
framework, I categorized support for clinical terminology standards as an organizational
capability. Sitapati et al. (2017) also explained that standards for some types of data used
in precision medicine need further development and adoption. Congruent with the view
provided by Sitapati et al. (2017), the development, maturity, and uptake of standards for
data exchange was deemed an important and feasible information technology resource for
precision medicine in healthcare delivery organizations and was categorized as an
organizational capability. The literature contains several articles that include discussions
about data standards in the context of precision medicine. As another example, Warner,
Rioth, et al. (2016) discussed the use of the Fast Healthcare Interoperability Resources
standard in the creation of a software program to deliver genomic information in a
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clinical environment for oncologic precision medicine. Congruent with the discussion by
Warner, Rioth, et al. (2016), both the physical information technology resource named
Fast Healthcare Interoperability Resources and the human counterpart named Fast
Healthcare Interoperability Resources expertise were deemed important and feasible for
precision medicine in healthcare delivery organizations. Information technology
resources related to data standards deemed important and feasible for precision medicine
in healthcare delivery organizations are congruent with discussions in the literature.
Information technology resources dealing with clinical decision support
considered important and feasible for precision medicine in healthcare delivery
organizations are consistent with cases found in the literature. For example, in one case
Hicks, Stowe, et al. (2016) explained that a multistate health system used custom rules
for clinical decision support when implementing pharmacogenomics, which is a form of
precision medicine. Consistent with the case discussed by Hicks, Stowe, et al. (2016),
clinical decision support customizability was considered an important and feasible
physical information technology resource for precision medicine in healthcare delivery
organizations. In another case, Danahey et al. (2017) discussed how a university affiliated
healthcare delivery organization integrated a standalone clinical decision support system
with an electronic health record system to aid healthcare workers when making
medication prescribing decisions for precision medicine. Consistent with the case
discussed by Danahey et al. (2017), the ability to integrate external clinical decision
support with the electronic health record was considered an information technology
resource that is important and feasible for precision medicine in healthcare delivery
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organizations and was categorized as an organizational capability. In a third case, Dolin
et al. (2018) developed a clinical decision support service for pharmacogenomics using
Fast Healthcare Interoperability Resources. Consistent with the case discussed by Dolin
et al. (2018), a Fast Healthcare Interoperability Resources clinical decision support tool
was considered an important and feasible physical information technology resource for
precision medicine in healthcare delivery organizations. Information technology
resources dealing with clinical decision support considered important and feasible are
consistent with cases found in the literature.
Information technology resources regarding interdisciplinary efforts deemed
important and feasible for precision medicine in healthcare delivery organizations are in
line with literature references. Prosperi et al. (2018) explained that precision medicine
requires interdisciplinary expertise. Additionally, Xu et al. (2021) provided the view that
medical informatics in the context of precision medicine has an interdisciplinary nature.
Furthermore, Brown (2016) discussed that technical solutions for precision medicine can
be enabled using interdisciplinary efforts. In line with Prosperi et al. (2018), Xu et al.
(2021), and Brown (2016), human information technology resources deemed important
and feasible for precision medicine in healthcare delivery organizations include: (a) the
necessary subject matter experts across a variety of disciplines; (b) a clinical informatics
team composed of physician informaticists, molecular medicine subspecialists, and
geneticists; and (c) collaborative teams that include experienced physicians working with
engineers and data scientists. Information technology resources regarding
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interdisciplinary efforts deemed important and feasible are in line with literature
references.
Information technology resources considered important and feasible for precision
medicine in healthcare delivery organizations that are related to genomics are in accord
with discussions in the literature. For example, Rasmussen et al. (2019) discussed that a
university affiliated healthcare delivery organization developed an ancillary genomics
system that imports genomic test results from laboratories, processes the test results, and
provides the test results to an electronic health record system. In accord with the
discussion by Rasmussen et al. (2019), a genomic storage and processing system was
considered an important and feasible physical information technology resource for
precision medicine in healthcare delivery organizations. As another example, Manzi et al.
(2017) discussed that a children’s hospital records genomic variants and interpretations of
the variants in an electronic health record system for pharmacogenomics. In accord with
the discussion by Manzi et al. (2017), the ability to capture genetic variants and their
meaning in genomic sequence was considered an important and feasible information
technology resource for precision medicine in healthcare delivery organizations and was
categorized as an organizational capability. As a third example, Swaminathan et al.
(2016) discussed three application programming interfaces focused on genomics that can
be used to access genomic data sources, such labs that perform genetic testing. In accord
with the discussion by Swaminathan et al. (2016), an application programming interface
with labs that offer genetic or precision testing was considered an important and feasible
physical information technology resource for precision medicine in healthcare delivery
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organizations. Information technology resources considered important and feasible that
are related to genomics are in accord with discussions in the literature.
Limitations of the Study
A limitation was that this study was subject to self-selection bias in that the
sample was composed of specialists who chose to participate. Knowledgeable experts
may have opted not to participate in the study due to time constraints, indifference to the
study, or insufficient compensation. In addition to offering a modest monetary gift, I
partially addressed the first limitation by using questionnaires that did not require a
substantial amount of time to complete.
Another limitation was that I used a cross-sectional design rather than a
longitudinal design. A cross-sectional investigation is useful to analyze data for a specific
point in time (Babbie, 2017) and does not provide information on how time may be an
influence (Caruana et al., 2015). An example of the cross-sectional design limitation is
that, according to McCoy (2017) and Vogl et al. (2018), research participants’
perspectives may change over time. I partially addressed the second limitation by using a
process to form consensus among the study participants. A consensus approach may have
created a balanced perspective and incorporated persisting elements regarding the
research questions.
A third limitation was that most of the participants stated they reside in the United
States. There are many differences in healthcare systems of other countries when
compared to healthcare in the United States. (Toth, 2016). The generalizability of the
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study to countries not represented in the sample is unknown. Considering differences in
healthcare systems across different countries is beyond the scope of this study.
Recommendations
Having identified several information technology resources for precision
medicine in healthcare delivery organizations, there are multiple opportunities to conduct
additional research about the information technology resources. One research opportunity
is to further investigate information technology resources that I considered to have
undetermined importance, undetermined feasibility, or both. As of this writing, it is
unknown why some information technology resources have undetermined importance or
feasibility. Another research opportunity is to explore contextual information regarding
the information technology resources. The need for a specific information technology
resource may be affected by the context in which it is used. A third opportunity for
further research about the information technology resources identified is to investigate
particular groupings of information technology resources. It is possible that some
combinations of information technology resources may be more beneficial than others.
Another opportunity to conduct additional research is to explore how the information
technology resources that I categorized as organizational capabilities are built and
embedded within a company in the context of precision medicine. It may be useful to
understand how much time and effort is needed to create an organizational capability.
There are multiple opportunities to conduct further research about the information
technology resources that I identified.
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Based on the study limitations, there are multiple opportunities to conduct further
research on the central topic that I examined. To recap the limitations, I conducted the
study at a point in time using a sample of individuals that mostly resided in the United
States and chose to participate knowing they were eligible to receive a modest monetary
gift. Since I conducted the study at a point in time, there is a research opportunity to
revisit the topic that I examined in the future. Given that the field of precision medicine is
emerging, new developments could affect information technology resource importance
and feasibility for precision medicine in healthcare delivery organizations. Considering
that most participants stated they resided in the United States, further research could be
conducted on the topic that I examined by targeting foreign countries. Research focused
on foreign countries could result in additional insights. Because the study was dependent
on individuals who chose to participate knowing they were eligible to receive a modest
monetary gift, there is a research opportunity to conduct a study on the topic that I
examined by using stronger incentives to entice knowledgeable individuals to participate.
Using stronger incentives to attract knowledgeable individuals could result in
incorporating other viewpoints. There are multiple opportunities to conduct further
research based on the study limitations.
Implications
At a societal level, the study results could give rise to positive social change by
enabling progress toward improved healthcare quality using information technology
resources for precision medicine in healthcare delivery organizations. Information
technology resources for precision medicine are underutilized, which can lead to adverse
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effects healthcare quality (Caraballo, Bielinski, et al., 2017). Having created a list of
information technology resources considered important and feasible, the study results
could create a shared vision of what is needed to fulfill information technology resource
requirements for precision medicine in healthcare delivery organizations. Creating a
shared vision could lead to improved utilization of information technology resources for
precision medicine in healthcare delivery organizations as well as improved healthcare
quality. The study results could prompt positive social change at a societal level by
enabling progress toward improved healthcare quality.
In addition to positive social change at a societal level, the study results could
lead to positive social change at an organizational level by informing information
technology resource decisions for precision medicine in healthcare delivery
organizations. For instance, reports indicate there is a shortage of information specialists
with the skills necessary to implement precision medicine (Gómez-López et al., 2019;
Hulsen et al., 2019). Positive social change could result by educational organizations
considering the study results when making decisions about enhanced curricula targeted at
people who function as human information technology resources for precision medicine
in healthcare delivery organizations. Enhanced curricula may help alleviate the shortage
of information specialists. As another example, multiple reports suggest that
commercially available information technology products are not mature in terms of
meeting the requirements for precision medicine in healthcare delivery organizations
(Hoffman et al., 2016; Warner, Rioth, et al., 2016). Positive social change could result by
commercial vendors considering the study results when making decisions about the
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creation of new physical information technology resources that would meet the
requirements for precision medicine in healthcare delivery organizations. As a third
example, reports indicate that data storage approaches used in early precision medicine
implementations may be insufficient for the long term (Danahey et al., 2017; Hicks,
Dunnenberger, et al., 2016). Positive social change could result by healthcare delivery
organizations considering the study results when making decisions about the creation of
adaptable data storage solutions for precision medicine. Adaptability could help increase
the longevity of data storage solutions. The study results could lead to positive social
change by informing decisions made by organizations regarding information technology
resources for precision medicine in healthcare delivery organizations.
Besides positive social change at organizational and societal levels, the study
results may lead to positive social change at an individual level by advancing the intellect
of people. I conducted this study in part because the literature did not contain a consensus
of information technology resource importance and feasibility for precision medicine in
healthcare delivery organizations. Considering that this study addresses a literature gap,
individuals that read this dissertation may benefit intellectually. The study results may
lead to positive social level change at an individual level.
As well as having implications for positive social change, the study results could
accelerate developments in theory. Given the emerging state of the field of precision
medicine, the results could provide a new perspective to advance concepts associated
with information technology resource planning when future circumstances are unclear.
Additionally, having determined information technology resource importance and
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feasibility, the study results could inform conceptual models concerning the evolution of
information technology resources for precision medicine. Furthermore, the results could
lead to a better understanding of how the dynamics of information technology resources
for precision medicine influence society. The study results could contribute to different
types of advancements in theory.
In addition to social and theoretical advances, the study results could contribute to
improvements in practice. The results could aid people in making strategic planning
decisions regarding information technology resources for precision medicine in
healthcare delivery organizations. Additionally, the study results could be insightful to
people when prioritizing resource investment options. Furthermore, the results could be
useful to people when assessing opportunities to create new information technology
resources for precision medicine in healthcare delivery organizations. This study could
lead to improvements in practice in multiple ways.
The study results could enable practitioners to be more efficient. Practitioners
could save time by using the list of information technology resources as a checklist of
resources to consider when making decisions regarding precision medicine in healthcare
delivery organizations. Additionally, practitioners could use the list of information
technology resources to consider information technology resources in an organized and
more complete way. Furthermore, the list of information technology resources could be
used by practitioners as a delegation aid when assigning tasks. There are multiple ways in
which the study results could enable practitioners to be more efficient.
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Conclusions
Healthcare delivery organizations have a tremendous opportunity to use insights
from the emerging field of precision medicine to improve the quality of healthcare
(Starkweather et al., 2018; Weinshilboum & Wang, 2017). Achieving the potential
benefits of precision medicine entails utilizing diverse and complex types of healthcare
data with the aid of information technology (Gligorijević et al., 2016; Gómez-López et
al., 2019). However, healthcare delivery organizations underutilize information
technology resources for precision medicine which can lead to adverse effects on the
quality of services provided (Caraballo, Bielinski, et al., 2017). In addition, people have
limited information to use when making decisions regarding information technology
resources for precision medicine in healthcare delivery organizations given the emerging
state of precision medicine.
The study results provide information that could benefit individuals,
organizations, and society regarding information technology resources for precision
medicine in healthcare delivery organizations. People that consider the results could
benefit intellectually. Organizations could benefit by using the study results to inform
decisions regarding information technology resources. The study results could benefit
society by creating a shared vision and enabling progress toward improved healthcare
quality.
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